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Abstract 
Diaryliodonium salts offer potential as novel reagents for arylation chemistry.  An 
overall goal and successful outcome of this work has been to further understanding of 
diaryliodonium salt chemistry by developing practical methods that enable chemists 
more convenient access to these reagents, for the purpose of reaction development. To 
this end a robust and convenient preparation method has been developed and resulted 
in novel commercially available diaryliodonium salts.  The remainder of the work 
described, has focused on understanding the parameters important to diaryliodonium 
mediated arylation and has resulted in a solid framework that multiple future 
development efforts can build upon. 
A strategy adopted throughout this work was to use multivariate methodologies such as 
Design of Experiments (DoE). Applicable chapters show the results of optimization 
studies that were carried out using DoE, during the course of this work. Additionally, the 
desire to further realize the potential that DoE has to offer inspired of a search for 
parameters to study fundamental reactivity. Chapter 2 details the development of a 
practical diaryliodonium salt synthesis that is convenient, facile, and economical.  A 
detailed procedure is also included and was drafted to the requirements for publication 
in the journal Organic Synthesis.  Finally, limitations and future directions of the method 
are discussed. Chapter 3 describes studies aimed at understanding the role of the 
counter anion; a very practical counter anion screening method is presented.  Future 
directions are discussed and include detailed characterization of diaryliodonium salts by 
NMR. Chapter 3 also describes a practical, scalable, and rapid salt exchange method 
  ii 
developed during this work. Chapter 4 describes the results obtained in studying an 
azidation reaction via solubility parameters. All Supporting Information, including 
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1. Introduction 
1.1. Significance 
Molecules containing aryl motifs are important to our daily lives and are implicated in 
pharmaceuticals, agrochemicals, engineering plastics, dyes for textiles and diagnostic 
sensing, and many other technologies that help to shape the way we live.  Figure 1 
shows several molecules that have impacted the lives of people globally and 
demonstrates that substituted aryl groups are a common feature of molecules in diverse 
and impactful applications. Notably the active pharmaceutical ingredients (APIs) of non-
steroidal anti-inflammatory drugs (NSAID; 1,2,3);  fluorescent dyes, such as rhodamine 
(4); polyethersulfone (PES, 7); and sulfonated PES (8).
   
 
Figure 1. Applications of molecules containing aromatic moieties.  
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Arguably, the types of substitutions and the substitution pattern of a given arene define 
its behavior and structure-function relationship (SFR).  For example, substituting a single 
hydrogen for a sulfonate group converts the commodity polymer, PES (7) into 
sulfonated-PES (8), (Figure 1).  Comparison of 7 and 8 nicely shows how a single 
substitution sufficiently alters the SFR so that the new material now finds application as 
a cation exchange resin.  Sulfonated-PES is no longer a suitable engineering 
thermoplastic as is 7.  Figure 2 shows a generalized arylation reaction, wherein a single 
aryl hydrogen is substituted for another functional group.  Broadly defined, arylation is 
the set of chemical transformations that result in the functionalization of arenes.  To this 
end, the work described here focuses on the discovery and improvement of reagents 
useful for arylation reactions.   Generally applicable reactions lead to simplified 
synthetic preparations of aromatic compounds, thereby reducing the resource demands 
of chemical synthesis and also facilitating the creation of novel compounds.    Therefore, 
developing more general arylation chemistry would, in effect, render it more useful to 
synthetic chemists.  Simplified syntheses and preparations of novel chemicals are two 
key outcomes that justify continued reaction development within this niche.  One long 
term benefit of continued development could be an increased variety of chemicals 
available to chemists.  Greater variety of available chemicals will increase the number of 
potential applications as well as further understanding of structure-to-function.  
  3 
1.2.  The status of contemporary arylation 
  Arylation has been the subject of intense research for over two centuries. The current 
state-of-the-art for arylation is dominated by transition metal catalysis (TMC), which has 
brought tremendous advances to synthetic chemistry.1  Despite its popularity, there are 
situations which clearly demonstrate the need for alternatives.  Specifically, the 
combination of late-stage synthesis and TMC can be problematic due to the difficulty of 
removing trace metals from reaction products.2  Removal or reclamation/reworking of 
the metals used in catalysts may serve to reduce manufacturing costs associated with 
waste.  Additionally, products manufactured in regulated industries are required to 
comply with requirements of the applicable regulatory agency. For example, the FDA 
has set strict criteria for acceptable trace metal content in APIs.3  Trace metal removal is 
challenging, in part, because the allowable concentration limits for trace metals are very 
low in comparison to commonly employed catalyst loading used in chemical synthesis. 
For example, the Losartan synthesis, shown in Figure 3, used a one mole percent loading 
of palladium acetate, which corresponds to roughly 1600 ppm palladium. 4  The limit in 
 
APIs for residual palladium is less than 10 ppm for oral administration and less than 1 
ppm for parenteral administration.5 As reported by Garrett, even after treatment with 
 
Figure 2. Late stage use of TMC. Metal content is contrasted with regulatory limits for Pd in APIs.  
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tributyl phosphine, about 50 ppm palladium remained.6  Notably, tributyl phosphine is 
itself moderately toxic, has a strongly unpleasant smell, and generally must be used in 
an air free environment.  
A metal-free arylation reaction could simplify syntheses in regulated industries by 
eliminating the need for catalyst removal and associated verification testing.  The cost of 
TMC can also be very high, in particular, when precious metals and custom ligands are 
required.  There are many examples that suggest the cost of designer ligands far 
outweighs the cost even of the precious metal component.  For example, 100 mg of the 
generation 3, Buchwald Palladacycle, CAS 1536473-72-9, from Strem Chemicals, sold for 
seventy dollars (December, 2015).  Based on the December 28th, 2015 closing price of 
one troy ounce of palladium ($554), one hundred milligrams would have cost just shy of 
two dollars.7  Based on the cost of one gram of palladium chloride, roughly sixty dollars, 
the cost for one hundred miligrams is about six dollars. The significantly higher price of 
the palladacycle when compared to a precious metal is plausibly indicative of the 
development cost associated with catalysts bearing designer ligands.  An inherent 
characteristic of TMC with designer ligands is that they catalyze a specific 
transformation very well, but are not generally applicable to many different 
transformations. This keeps the likelihood of ligand development high, whenever novel 
reactivity is considered. Also, TMCs are frequently moisture- and/or air-sensitive and 
greater availability of bench-stable reagents would lessen the environmental controls 
and maintenance needed for storage and processing.  Finally, an important distinction 
to remember is that TMC’s are catalysts and not reactants.  Developing reagents that 
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accommodate a broad substrate scope without added catalysts is a useful effort 
because, it is complementary to current technology. Although the point has been made 
that reagents capable of metal-free reactivity will avoid the cost of transition metal 
catalysts and associated ligand development, it is noteworthy that this does not 
preclude the addition of a TMC if needed. The reagents that will be discussed in this 
work are not catalysts and are not offered as a competing technology to TMC.  A more 
realistic view would be that efforts to develop reagents capable of metal-free reactivity 
are complementary and so will hopefully lower dependence on TMC by offering the 
chemist greater flexibility in chemical synthesis.  A particularly attractive scenario would 
include the discovery of reagents that undergo specific transformations that may be 
tuned with reaction conditions.  
1.3. Diaryliodonium salts as arylation reagents 
Diaryliodonium salts represent a potential alternative for arylation reagents and have 
been shown to mitigate several of the gaps in the toolkit currently available to chemists.  
In his 2016 review, Zhadankin asserts that iodine reagents, in general, are viable as 
sustainable alternatives to metals, because iodine is itself relatively more 
environmentally benign, cheap, and sufficiently abundant.8  Global crude iodine 
reserves are primarily found in Chile and Japan and its price is listed as $23/kg by the 
United States Geological Survey (USGS). 9   In contrast the 2016 prices of platinum and 
palladium listed by the USGS were $1000 per oz. ($32,151 per kg) and $615 per oz. 
($19,773 per kg), respectively.  Currently, 30,000 metric tons of iodine are harvested 
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annually and the estimated worldwide reserves are about 15 million metric tons. 10 
While this is not by any means a rigorous cost analysis, it seems that given the chance to 
become mainstream reagents, iodine based compounds could be economically 
competitive to their more expensive transition metal based counterparts. 
Diaryliodonium salts enable transfer of aryl groups to heteroatoms as well as carbon 
atoms and are generally used under mild conditions, do not require inert environments 
or forcing conditions and may be used alone or with a transition metal. The vast 
majority are bench stable compounds and require minimal environmental controls to 
use.  Together, the characteristically mild conditions, broad substrate scope, and 
regiospecificity possible with diaryliodonium salts make them a potentially useful 
reagent for late stage functionalization of complex arenes.  The ability to perform 
specific and selective late stage transformations with a metal-free reagent is of 
particular value in the pharmaceutical industry, where strict limits on residual metal 
content must be met.   
1.4. Historical overview of diaryliodonium salts 
First discovered in the 1890’s by Wilgerodt,11 the potential breadth of arylation 
reactions with diaryliodonium salts was first demonstrated by Beringer in the 1950’s.12  
Later, in the 1970’s, efforts were made to characterize their structures and to begin 
understanding basic reactivity of hypervalent iodine compounds including, 
diaryliodonium salts.  Several reviews are available for further reading on the overall 
class of hypervalent iodine reagents and their application for small molecule synthesis.13  
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In the 1970’s, Crivello and coworkers reported that diaryliodonium salts may be used as 
photo-acid-generators (PAGs).14   As polymerization initiators in photoresists, 
diaryliodonium salts have had an enormous impact on the development of modern 
electronics.15 Today, research into hypervalent iodine reagents is gaining popularity as 
they offer an attractive combination of qualities including generally good stability and 
versatile chemical reactivity.  They offer the potential for tuning reactivity according to 
reaction conditions, and as nonmetals, may eliminate the need for metal removal.  To 
date, hypervalent iodine reagents, including diaryliodonium salts have become accepted 
reagents for natural products and pharmaceutical synthesis.16   While this work is 
focused on the development of specific diaryliodonium reagents and some aspects of 
their behavior in closed-shell arylation reactions, it is warranted to provide a brief 
discussion of hypervalent iodine as well as some of its history.    
1.5. Overview of diaryliodonium salt structure and reactivity 
Every organic chemistry student is first introduced to organoiodine with iodine existing 
as an organoiodide. Undergraduate courses rarely, if ever, mention the higher oxidation 
states, (+III) and (+V), which have found considerable use in small molecule synthesis, 
functional group transformation and polymer chemistry.  Figure 4 shows the general 
structures of aromatic organoiodine compounds in various commonly encountered 
configurations.  Diaryliodonium salts, less commonly called λ3-diaryliodanes, are a sub-
class of hypervalent iodine(III) reagents.  The T-shaped structure in Figure 4 and Figure 
5, has been experimentally determined by X-ray crystallography for numerous 
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diaryliodonium compounds.17  It follows that for crystalline diaryliodonium salts, the T-
shape structure has been used to rationalize the thermodynamic stability of 
diaryliodonium salts.  There has been controversy in the literature over whether these 
compounds are really salts. For clarity, referring to a diaryliodonium compound as a 
“diaryliodane” suggests that it is not a salt and that the X-group is bound to the iodine 
via a dative bond.  Whether these comounds exist in the diaryliodane form, or in the 
ionic diaryliodonium form is debated in the literature.  This author contends that the 
structure at any given moment likely depends foremost on the state of solvation as well 
as the identity of X. Regardless, the T-shape is also important for understanding the 
outcome of the putative reductive-elimination pathway that has been described for 
diaryliodonium mediated arylation. 12k      
Many derivatives of the general structures shown in Figure 3, are bench stable and 
commercially available from mainstream chemical suppliers.  In fact, polycoordinate 
compounds have been reported for the entire halide family, except fluorine and are 
collectively referred to as halonium compounds. 
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Reagents such as hydroxy(tosyloxy)iodoarenes (HTIA, Figure 4a) and Dess-Martin 
periodinane (DMP, Figure 4c) act as oxidants and have been widely used. HTIA 
additionally has been used for ligand transfer of the sulfonate group. Iodoaryl dihalides  
have been used to access high oxidation states in metal reagents and also may be used 
as ligand transfer reagents, for example halogenation of an alkene. Both the dihalide 
and diacetoxy species may be used as chain transfer reagents in radical polymerizations.  
The diacetoxy species may also be used in oxidative coupling reactions, for example in 
the homocoupling of n-heterocyclic carbenes (NHCs).  Uniquely, diaryl-, alkenyl- and 
alkynyliodonium salts are carbon transfer reagents. Chapter 2 presents the detailed 
 
Figure 3. General structures of commonly encountered hypervalent iodine.  
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development of a diaryliodonium reagent, which transfers aryl groups to nucleophiles 
and lies at the heart of the work presented here.  
 
 
The full scope of described structures is more complicated than might be expected, 
based on Figure 3. In fact, depending on the R-group and the environment, many of 
these structures can form dimers and oligomeric networks with potentially significantly 
different physical and chemical properties relative to the monomeric species.  Further 
discussion of these somewhat esoteric structures is beyond the scope of the material 
presented here. 
 
Figure 4.  The T-Shape structure of crystalline diaryliodonium salt. Collected with help of Dr. Kuo at 
Lewis & Clarke college.  
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The stability of diaryliodonium salts that have the general, T-shaped, crystal structure 
shown in Figure 4 is thought to depend on the configuration of ligands around the 
iodine center.  In the 1970’s, Shustorovich studied the, axially oriented, three-center-
four-electron (3c-4e) bond and its constituents. 
 
He suggests that both of the apical ligands of the 3c-4e bond of hypervalent iodine (III) 
compounds exert an inductive trans-influence on the opposite ligand, the strength of 
which depends on the σ -donating ability of both ligands.  The stronger σ-donor will 
have stronger bonding to the iodine center and will simultaneously weaken the opposite 
iodine-ligand bond. Shustorovich posited that, because of the trans-influence, the 
combination of one strong and one moderate sigma donating ligand would likely allow 
the 3c-4e bond the greatest thermodynamic stability.18  Accepting this rationale, it 
becomes clear that in a diaryliodonium salt, the 3c-4e bond will virtually always include 
one arene and the X-group, but a configuration with two apical arenes is very unlikely to 
 
Figure 5.  Structural features of the Ar2IX configuration15 
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occur.   Examples of all-carbon ligated iodine species have been reported, however, they 
were prepared at -80 ˚C and were extremely unstable. 19  
The reactivity of diaryliodonium salts as electrophilic carbon transfer agents is justified 
by the charge polarization of the 3c-4e bond.  The iodine center effectively carries a +1 
charge, making it inherently electrophilic and allowing for attack by nucleophiles.  A 
second feature that is often cited is the excellent leaving ability of the aryliodide moiety 
which has been called a hypernucleofuge. An example of the leaving ability of Ar-I is 
presented in Figure 6 below. 20 
 
There are three main modes of reactivity by which arylation reactions of diaryliodonium 
salts are thought to proceed.  Of the three pathways (Figure 7), the ionic (closed-shell) 
pathway is most developed, in particular, for arylation with heteroatoms21a-l.  The work 
here is primarily concerned with reagent development and the work presented here on 
coupling reactions is exclusively using nucleophiles that proceed through the ionic 
pathway.   The radical and benzyne pathways will not be discussed further. 
 
Figure 6.  Ochiai determined that the I-Ph behaved as a hypernucleofuge via comparison to the 
same reaction with other leaving groups.  
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The ionic mechanism is thought to occur according to Figure 8. The nucleophile 
undergoes metathesis with the X-group, followed by formation of a three membered 
transition state, wherein the nucleophile is transferred to the equatorial-aryl group by 
reductive elimination.   The reaction results in arylation of the nucleophile and a 
stoichiometric amount of an aryl iodide co-product.   
 
An inherent advantage of diaryliodonium salts, undergoing coupling via reductive 
elimination, is that they affect an ipso-substitution and so offer excellent and 
predictable regiospecificity. It is immediately apparent that chemoselectivity is not an 
issue for the reaction shown in Figure 8.  This is because the diaryliodonium salt shown 
 
Figure 7. Three common modes of diaryliodonium salt reactivity.  
 
Figure 8. The putative mechanism for the ionic, 2-electron coupling pathway, proceeding via 
reductive elimination.  
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has two identical aryl groups.  Such a diaryliodonium salt is termed symmetrical.  In 
contrast, chemoselectivity does become important when considering arylation with 
unsymmetrical diaryliodonium salts.  Figure 10 shows two aspects of unsymmetrical 
diaryliodonium salts that are needed to understand how chemoselectivity occurs and 
ultimately how it may be controlled.   
 
Firstly, the T-shape helps to visualize that once the nucleophile replaces the X-group it 
can only reductively eliminate with a ligand in the equatorial position.  Secondly, 
isomerization via pseudorotation means that both arenes may occupy the equatorial 
position.   This means that both aryl groups have opportunity to enter the transition 
state preceding reductive coupling and that the product distribution will be determined 
by the relative energies of the two possible isomers of the transition state.   
1.6. Selectivity with unsymmetrical salts 
In practice, selectivity of the reaction and the resultant product distribution may be 
modulated by tuning the physicochemical properties of both arenes.   Considering the 
 
Figure 9. Pseudorotation isomerizes aryl groups between axial and equatorial positions.  
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ideal 
case, where one arene always leaves as its iodide, then it becomes reasonable to  
label it as an auxiliary group (Aux). Unsymmetrical diaryliodonium salts are contrasted 
with their symmetrical counterparts in Figure 10 and may be described as consisting of 
four components: the iodine center, the X-group, the Ar group and AuX-group.  In a 
coupling reaction, the Ar-group is the intended coupling partner and the Aux-group is 
intended to leave as its iodide. 
The practical result of the distinction between Ar and Aux is that when a symmetrical 
salt undergoes a coupling reaction an equivalent of Ar is lost.  The potential significance 
of losing an equivalent of Ar is explained by the hypothetical late stage functionalization 
of Flubendiamide (Figure 11). 
 
Figure 10. Anatomy of symmetrical and unsymmetrical iodonium salts 
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While the aryliodide co-product from reaction of the symmetrical salt in Figure 11 can 
potentially be reworked, such an undertaking would at best be mitigating and cannot be 
viewed as a solution.   This limitation makes symmetrical diaryliodonium mediated 
arylation of elaborate products untenable.  On the other hand, if the leaving moiety can 
reliably be the iodide of a simple arene, then waste is minimized and a workable 
situation may be realized. 
The source of selectivity was studied in detail by Togni.22  He suggests that in the 
absence of sterics, the 3c-4e bond polarity, and in particular the charge of the ipso-
carbon in the 3c-4e bond, determine the selectivity.  More specifically, Togni calculates 
the partial charge on the ipso-carbon of both arenes when they are in the axial position.   
The difference of partial charges at the ipso-carbon for variously substituted rings is 
 
Figure 11.  Hypothetical late stage functionalization using a symmetrical iodonium salt of  
Flubendiamide Bayer CropScience (2006).  
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shown to correlate well with the activation barrier to reach the transition state (Figure 
12).   
 
There are numerous examples in the literature that corroborate Togni’s findings and it 
generally holds true that the more electron poor ring will couple to a nucleophile. Togni 
was also able to show that the correlation between ipso-carbon charge and activation 
barrier does not hold when one of the ligands is stericaly congested.  These results 
support experimental observations that the more electron rich ring, if bulky, can be the 
favored coupling partner (Figure 13).  
Wiegend, who first suggested the ortho-effect, performed pyrolysis experiments with 
diaryliodonium halides and showed that steric bulk in the ortho-position influences the  
 
Figure 12. The difference in the transition state (TS) energies of the pseudorotated isomers 
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reaction outcome, however, no unambiguous trend was presented.23  Consequently, it 
is assumed that the bulkier group occupies the “roomier” equatorial position in the 
transition state. The cumulative data from the literature regarding this so-called ortho-
effect is not straightforward.  For example, Olofsson provides data showing that, in 
certain cases, steric bulk of the nucleophile may also play a role in determining 
selectivity of coupling (Figure 5).24  Olofsson reported that the bulky nucleophile exerted  
an “anti-ortho-effect”, much to the chagrin of the encumbered ring. Pike and 
Widdowson additionally have shown evidence of the ortho-effect in fluorination 
reactions.25  As such it is difficult to outline a general trend across all nucleophiles with a 
single sterically and electronically defined diaryliodonium salt.  The observed anti-ortho-
effect strongly alludes to the importance of including all components comprising the 
 
Figure 13. Togni's computational work shows the relative transition state energy is consistent with 
the criteria for Curtain-Hammet kinetics.  
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transition state as well as those that are part of intermediate structures leading to the 
transition state.  These components necessarily include the auxiliary, the aryl group, the 
X-group and the nucleophile.   The X-group and the nucleophile have received very little 
attention to date.  Even empirical studies of the X-group are rare and not 
comprehensive to the point that no parameter with which to evaluate the counteranion 
has been proposed.  Most often, authors have simply stated that “non-coordinating” 
anions are preferable, such as triflate or tetrafluoroborate. 26 An interesting 
consideration to include would be solvent identity, simply because salts or salt-like 
species are directly involved in the reaction until reductive elimination occurs.  In 
particular with salts, the coordinating effect of certain solvents could play a role.  It is 
conceivable that a certain coordinating solvent would increase solvation and drive apart 
the X-group and leave the iodonium center available for attack.  It is also conceivable 
that a solvent could coordinate too effectively, replace the X-group, but also hamper 
approach of the nucleophile. 
1.7. Trimethoxyphenyl as an auxiliary  
The value of the computational work by Togni is that it helps to rationalize a conceptual 
framework that corroborates empirical observations that sterically unhindered, electron 
rich, arenes preferentially leave the coupling reaction as their iodide.  Diaryliodonium 
salts bearing a 2,4,6-trimethoxyphenyl (TMP) group have been demonstrated by several 
authors, notably Olofsson and Pike, to provide excellent selectivity across several 
nucleophiles (Figure 14). 27  
  20 
The realization of a diaryliodonium salt with generally excellent selectivity completes a 
paradigm shift away from the symmetrical diaryliodonium salt. Despite the advantages 
of the trimethoxyphenyl auxiliary 
being reported already a decade 
ago, no convenient preparation of 
these reagents was described.  As a result, reaction development efforts have rarely 
focused on TMP containing diaryliodonium salts and selectivity remained an issue. 
Previously reported syntheses of TMP containing diaryliodonium salts required an I(III) 
starting material and took multiple steps with overall moderate yield.  The work 
described in Chapter 2 shows that aryl(TMP)iodonium salts are now readily prepared in 
under an hour, greatly facilitating reaction development with these promising reagents. 
1.8. Overview of the preparation of diaryliodonium salts 
Most often, the route to build diaryliodonium salts involves first oxidation of an 
iodoarene to the +3 oxidation state, followed by installation of the second arene via 
electrophilic aromatic substitution.  Figure 15 shows four distinct methods to build 
diaryliodonium salts.   Of these methods, the simplest in practice are those using an 
oxidant in conjunction with a Bronsted acid as cooling below zero centigrade is rarely 
required.  The reaction using molecular iodine is useful for symmetrical salts and when 
more than one arene is present a statistical product mixture will result.  Reactions 
employing boron trifluoride etherate tend to require lower temperatures often and 
moisture can be an issue.  The reaction using boronic acids has the benefit of good 
  
Figure 14. Assymmetric diaryliodonium salt configuration 
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tolerance for electron rich iodoarenes, which have been problematic in reactions 
employing Bronsted acids.   
 
1.9. Design of Experiments (DoE) 
Design of Experiments (DoE) is a methodology that employs multivariate analysis to test 
a given hypothesis.  It originated from the work of William Gosset, who was working to 
improve batch consistency at the Guinness Brewing Company and so was concerned 
over statistics with small sample sizes.  Gosset’s work was published under the 
pseudonym, Student, and his ideas on “designed experiments” were later developed by 
scientists like Fisher and Taguchi.  Today, industry commonly employs DoE during the 
development phases of R&D projects and heavily relies upon DoE for the creation of 
 
Figure 15. Common routes to prepare diaryliodonium salts.  
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robust manufacturing processes.  DoE is rare in academic organic chemistry laboratories 
in North America and formal training is hard to find.  It was successfully implemented 
for the optimization of a diaryliodonium salt preparation (Chapter 2) as well as for an 
azidation reaction (Chapter 3).  The workflow in Figure 16 describes one, albeit simple, 
implementation of DoE.  Importantly, optimization may be considered complete when 
the results of confirmation runs are in sufficient agreement with results predicted by the 
model.    
An initial, 2-level fractional factorial design allows the relative contributions of many 
factors to be efficiently assessed and unimportant factors need not be studied further 
(Figure 16, Phase 0).  Because the designs in Phases 0 and 1 vary factors over 2-levels, 
data is necessarily fit to a linear model.  Despite the linear model, the use of center 
points in the initial 2-level design allows deviations from the linear fit to be detected.  
That is, if center point runs are statistically significant and do not fit to the linear model, 
curvature is indicated.  After culling unimportant factors the remaining ones can then be 
studied in enough detail to quantify interaction effects between them (Figure 16, Phase 
1).   An interaction occurs when the contribution of one factor on a chosen output 
depends on the level of at least one other factor.   Without simultaneously varying the 
levels of factors, the interaction effects may be overlooked and the importance of a 
factor may be overlooked.   The ability to assess interaction effects makes DoE 
inherently more accurate than the traditional One Variable At A Time (OVAT) method.   
Using OVAT relies on luck to stumble upon the optimal conditions.   
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Not immediately obvious from the workflow is that data from successive experiment 
designs may be combined.  The ability to grow the relevant pool of data by accretion is 
one way that using DoE can make optimization more efficient.  Curvature detected in 
Phase 0 or 1 may be characterized by augmenting the data set obtained from the 2-level 
factorial with the additional data points (levels) needed to apply a higher order model 
(Figure 16, Phase 2).  At this point the designs are often termed response surface 
analyses (RSA). Finally, regression analysis like ANOVA, various statistical tests and 
confirmation runs, are tools for objective evaluation of design models as well as, 
troubleshooting, and evaluation of design matrixes as well as results.   
A final comments regarding the usefulness of DoE for research in chemistry, is that the 
work presented here is only the tip of the iceberg.  This work only has dealt with the 
optimization of reaction environment and other variables that are easily controlled and 
continuous.  In other words, only conditions were studied.  Consider, however, the case 
where physicochemical parameters are used as inputs to experiment designs.  Then, 
conceptually, it becomes possible to use DoE and its advantages to study fundamental 
aspects of reactivity.  Here, useful physicochemical parameters include any quantifiable 
value that is directly or indirectly related to the fundamental properties of a molecule. 
For example, Hammet constants, peak locations of various substrates on a given type of 
spectrum, redox potentials, solubility parameters and even results from DFT calculations 
are all of potential use.  In chapter 3, the beginning of such work is presented by the 
study of yield as a function Hansen Solubility Parameters (HSP).  A difficulty that is not 
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immediately obvious is that it can be difficult to design symmetrical matrixes when 
using physicochemical parameters.  For example, the DoEs shown above use 
symmetrical ranges of input variables and this is possible, because the variables are 
continuous.  Here, physicochemical parameters are discussed as discrete variables with 
values that describe an inherent characteristic of a molecule.  The nature of DoE is that 
results are most reliable when the levels of input variables can be set over regular 
intervals. As a result, when dealing with physicochemical parameters of molecules, DoE 
matrices will not be perfect arrays of orthogonal factors and the methods to adjust both 
the designs and their analysis are beyond the scope of this work.  




Figure 16. Example DoE work-flow.  
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2. Developing the synthesis of aryl(TMP)iodonium tosylate 
2.1. Previously reported syntheses 
With the belief that diaryliodonium salts will only gain traction as mainstream arylation 
reagents after the described issues relating to selectivity have been overcome, the 
development of a practical synthesis of a selective diaryliodonium salt reagent became a 
priority. In particular for functionalization of elaborate molecules, it is necessary to 
move away from symmetrical salts in order to overcome an inherent limitation.   
 
Arylation with diaryliodonium salts has excellent precedent.  Still, current knowledge 
falls short when it comes to understanding exactly what reaction conditions, which 
combinations of reagents, and how the specific configuration of the diaryliodonium salt 
results in preference of one mechanism (ionic vs. radical vs. benzyne) over another and 
transfer of one aryl group over another.  Critics have alleged that these reagents are 
 
Figure 17. a) Previously reported route to TMP containing diaryliodonium salts; b) This work 
 
Figure XXX: a)Previously reported aryl(TMP)iodonium tosylate, b) this work 
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difficult to prepare and that they are not practical for use in modification of elaborate 
molecules, as encountered in late-stage synthesis of pharmaceuticals or in the post-
modification of polymers.   Our work, to date, has resulted in the development of a 
significantly improved method for the preparation of a variety of diaryliodonium salts 
and demonstrates successful coupling to elaborate arenes.  Our data shows successful 
use of Design of Experiment (DoE) approach in order to develop a practical synthesis of 
diaryliodonium salts.  The preparation is shown to be very repeatable and 
accommodates a broad scope of iodoaryl substrates.   The preparation described below 
has been published and has been adapted into an Org Syn method, which is presented 
in Chapter 2b.  As a final proof of success, several of the reagents have been made 
commercially available by TCI and are available in North America, Japan and Europe. 
2.2. Feasibility  
We have developed a robust synthesis of unsymmetrical (Figure 17b), 
aryl(TMP)iodonium tosylates and used DoE to arrive at optimized conditions with a 
model substrate.  Precedent for diaryliodonium salts and the justification for choosing 
trimethoxyphenyl based aryliodonium salts are discussed in previous sections. 
 
 
Figure 18. Application of aryl(TMP)iodonium salts.  
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The research groups of Olofsson and Pike previously demonstrated the importance of 
the trimethoxyphenyl auxiliary in diaryliodonium salts.28,29  The three methoxy groups 
on TMP are stable and sufficiently electron-donating to help to ensure that the auxiliary 
will be relatively more electron rich than the other arene.  The tosylate counteranion 
was selected according to precedent methods from the chemical literature.  Tosic acid is 
consumed during oxidation of the aryliodide (stage 1) and its conjugate base takes on 
the role of counter anion in the iodonium product.  Fortunately, the tosylate anion has 
proven to be very amenable to exchange by various alkali salts. Counter anion identity 
has been shown to significantly affect reaction outcomes and is discussed in detail in 
Chapter 3.  
Preparation of 10 was previously accomplished by first preparing the hydroxy 
(tosyloxy)iodoarene (HTIA) by Olofsson’s method 30 (Figure 19, Pot 1) and then reacting 
it further with TMB similarly to a method from Pike13 (Figure 19, Pot 2).  During 
feasibility experiments, it was observed that the rate of HTIA formation dramatically 
increased upon raising the concentration from 0.1 M to 1 M.  It was evident that 
Olofsson’s procedure had unrealized potential.  Feasibility tests also showed that it was 
possible to form the aryl(TMB)iodonium tosylate by adding TMB directly to the crude 
HTIA intermediate.  In order to further simplify and also to make the reaction more 
environmentally friendly, a single solvent, acetonitrile, was used for both steps of the 
reaction.   Using acetonitrile avoids the use of perfluorinated alcohols, which are costly 
and hazardous.   
  29 
 
Upon successful demonstration of feasibility, our one-pot reaction was optimized using 
DoE.  The optimization substrate chosen was 4-methyl-iodobenzoate.  The moderate 
yields of this substrate under feasibility conditions were thought to be directly related to 
the electron withdrawing nature of the ester group.  Feasibility work, performed with 4-
trifluoromethyl-iodobenzene and 4-tolyl-iodobenzene followed literature trends for 
formation of the HTIA intermediate. Consistent with expectations, more electron rich 
iodoarenes required shorter reaction times to form the HTIA analogue.   The literature 
shows that similar, two-pot, preparations of diaryliodonium tosylates, bearing auxiliaries 
other than TMP, were most challenging for iodoarenes bearing electron withdrawing 
substituents.  Initial one-pot experiments resulted in encouraging yields between 60% 
and 70%, indicating that the iodobenzoate substrate was a useful choice for 
optimization. 
 
Figure 19.  Feasibility Studies. Pot 1: Olofsson’s preparation of HTBIA; Pot 2: Modification of Pike’s 
procedure, which first required conversion of a diacetoxyiodoarene into HTBIA.  
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Optimization of the reaction shown in Figure 20 followed the work flow presented in 
Chapter 1, Figure 16, and resulted in model-predicted yields that agreed with 
experimentally obtained yields.  The predictive value of the model is supported by the 
confirmation run data listed in Table 9 and also plotted on the response surface in 
Figure 26.  The optimization was considered successfully concluded upon observing that 
the mean and standard deviation of the confirmation runs fell within those predicted by 
the model.  A very interesting result of early DoE runs was the unexpectedly fast 
reaction to install the TMP auxiliary. As a result, the reaction time of stage 2 was 
shortened to a practical limit of 5 minutes. A detailed description of the optimization 
process is provided in the following section.   
 
Figure 20. Reaction used for optimization.  
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2.3. Optimization Details 
General comments and a brief overview of DoE were given in Section 1.9. 
2.3.1. Assessment of main effects of 5 factors under study  
 
Main effects are the individual contributions of factors, excluding interaction effects 
(Figure 16, Phase 1).  A specific type of fractional factorial design, called a Plackett-
Burman design, was used. 31 This design is useful for assessing main effects of many 
factors in relatively few experiments. Assessing main effects can be a key step in DoE as 
it allows culling of factors that do not substantially contribute to the selected output, 
thereby reducing the subsequent work-load.  As mentioned, factors are studied over 
two levels and linear models necessarily apply. Nonetheless, the addition of replicate 
center points serves to: 1) provide an early assessment as to the presence or absence of 
curvature, and 2) provide an estimate of the experimental error, which here is taken as 
the standard deviation of the replicate runs.  An estimate of the experimental error is 
important as it determines the signal-to-noise ratio (S/N) of the results.  The S/N value is 
critical to determining the size of an observed change in an output that one may 
distinguish from noise, at a chosen level of confidence.  32 Estimating experimental error 
in this way makes the assumption that error is constant across the design space.  This is 
generally true, provided that whatever mechanism is driving the process under study 
also remains constant over the design space. 
 
Figure 21. Reaction used for optimization.  Factors under study were A through E.  
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In this case, twelve experiments were required to study five factors and five center 
points were added (Table 1).  For perspective, up to 28 experiments could be run in one 
regular work day.  Additionally, the use of coded and actual values to describe the levels 
factors are set at (Table 1) is discussed in Section 2.3.2.  
The Results of the Placket-Burman design are shown in Table 2 and Figure 22. Factors 
considered significant effects (A, B, D) are bolded in Table 2 and account for ~90% of the 
contribution to the measured response.  The “equivalents of TMB” factor was rejected 
from subsequent work because its effect was inversely proportional to yield.  Despite 
the low effect on yield, the reaction time of Stage 2 was included in subsequent 
experiment designs simply to satisfy the author’s curiosity.  However, it would have 
been justifiable to exclude Time 2 from further study.   
Factor Descriptionb low levela center levela high levela 
A Conc.   (M) 0.1 (-1) 0.55 (0) 1   (1) 
B Time 1 (min) 2  (-1) 16  (0) 30  (1) 
C Time 2 (min) 2  (-1) 16  (0) 30  (1) 
D Temp.  (˚C) 25 (-1) 53   (0) 80 (1) 
E TMB    (equiv)  1    (-1) 2.0  (0) 3    (1) 
        
Table 1. Summary of Placket-Burman design a Low and high levels are coded to -1 and +1 in order 
to assess the relative effect of each factor on %yield.  b “Time 1” and “Time 2” refer to reaction 
times for “Stage 1” and “Stage 2”, respectively. 
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2.3.2. Full Factorial to assess interaction effects of A, B, C, D   
The full factorial design allows identification of interactions between factors (Figure 16, 
Phase 1).  This design, with the four factors selected in the previous design, required 
sixteen experiments.  It would be possible to have first run the full-factorial and skipped 
the fractional factorial design altogether. However, the total number of runs is equal to 
the number of levels raised to number of factors under study.  This optimization was 
started with five factors, studied at two levels.  Starting with a full factorial in lieu of the 
fractional factorial design would have required 25, or 32, experiments.  Some replicate 





X1 = E: equiv. TMB
Actual Factors
A: Temperature = 52.5
B: Time 1 = 16
C: Time 2 = 16
D: concentration = 0.55
E: equiv. TMB (equ)




















X1 = C: Time 2
Actual Factors
A: Temperature = 52.5
B: Time 1 = 16
D: concentration = 0.55
E: equiv. TMB = 2
C: Time 2 (min)




















X1 = A: Temperature
Actual Factors
B: Time 1 = 16
C: Time 2 = 16
D: concentration = 0.55
E: equiv. TMB = 2
D: Temperature (degC)




















X1 = D: concentration
Actual Factors
A: Temperature = 52.5
B: Time 1 = 16
C: Time 2 = 16
E: equiv. TMB = 2
A: concentration (M)




















X1 = B: Time 1
Actual Factors
A: Temperature = 52.5
C: Time 2 = 16
D: concentration = 0.55
E: equiv. TMB = 2
B: Time 1 (min)
















Figure 22. Pl ts of 
effects A, B, C, D, E. 
Five center point runs 
are also shown in each 
plot.  In each plot, the 
x-axis runs from the 
low to the high value 
and the  y-axis from 0% 
to 100%. 
Factor Description %contribution 









D Temp.  (˚C) 30.35 
curvature - 31.94 










Pure error - 0.033 
  Sum =  ~100% 
Table 2. Contribution of factors, 
interactions and curvature to yield are 
shown (calculated with Design Expert 
software). 
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omitted from further study then the total number of experiments at this point would 
have been twenty-five:  seventeen from the Placket Burman plus another eight for the 
full factorial with factors A, B, D.   Hence, the stepwise approach to the methodology in 
Figure 16 is aimed at increasing efficiency of the overall process and this benefit should 
increase with the number of factors initially selected for study.
 
 
Table 3. Summary of full factorial design. 
Factor Descriptionb low levela high levela 
A Conc.   (M) 0.1 (-1) 1    (1) 
B Time 2 (min) 2    (-1) 30  (1) 
C Time 1 (min) 2    (-1) 30  (1) 
D Temp.  (°C) 25  (-1) 80  (1) 
 
 







      
A-Conc  Temp.  (˚C) 20.27 1642.37 10.93 
B-Time 1  Time 1 (min) 21.32 1817.60 12.09 
C-Time 2  Time 2 (min) -1.41 8.42 0.056 




3.37 45.39 0.30 
AC  -0.55 1.18 7.87E-003 
AD  6.04 145.87 0.97 
BC  1.4 7.97 0.053 
BD  0.059 0.014 9.19E-005 
CD  -2.01 16.64 0.11 
ABC  1.38 7.71 0.051 
ABD  -10.19 415.24 2.76 
ACD  0.50 0.98 6.49E-003 
BCD  0.52 1.21 8.03E-003 
ABCD  0.34 0.54 3.57E-003 
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The model at this point linear and already has good value for prediction. The linear 
equations including main effects and interaction effects are shown below.  Readers are 
encouraged to pay particular attention to Figures 23, 24 and 25 as they graphically show 
the importance of interaction effects.  Note that because each factor is varied over two 
levels, it is possible to code the lower level as (-1) and the higher level as (1).  The coded 
factors are each varied over the same range and so their contribution to the output may 
be directly compared and their relative importance assessed.  The relative contribution 
of factors A, B, D and their interaction effects, AB, AD, BD and ABD can be seen Table 5. 
The equation using the actual levels is predictive within the tested design space.  That is, 
the equation in terms of actual factors may be used to navigate the design space, but 
should not be used to extrapolate beyond the tested design.  
 






(Prob > F) 
< 0.0001 
The model is significant and there a 
0.01% chance this F-value could be 
due to noise 
Std. Dev. 2.35 R-Squared 0.9971 Predicted and Adjusted R-Squared 
values are <0.2 apart, indicating the 
model is appropriate for the data 
collected 
Mean 45.69 Adj. R-Squared 0.9945 
CV% 5.14 Pred R-Squared 0.9883 
PRESS 176.35 Adeq Precision 50.456 
This model can be used to navigate 
the design space due to sufficient 
signal-to-noise ratio. 
 




Equation in terms of coded factors:     
%𝑦𝑖𝑒𝑙𝑑 = 45.2 + 10.1𝐴 + 10.7𝐵 + 26.7𝐷 + 1.7𝐴𝐵 + 3.0𝐴𝐷 + 0.03𝐵𝐷 − 5.0𝐴𝐵𝐷  
 
Equation in terms of actual factors: 
%𝑦𝑖𝑒𝑙𝑑 = −5.37 − 23.1𝐴 − 0.25𝐵 + 0.52𝐷 + 1.93𝐴𝐵 + 0.78𝐴𝐷 + 0.02𝐵𝐷 − 0.032𝐴𝐵𝐷  
 
Table 6. Factors selected as model terms based on ANOVA and corresponding model equations. 
Factors that are not statistically significant are not included in the model unless required to support 
hierarchy, as with interaction term BD.  Prob > F values of less than 0.0500 are statistically 




Factor Description Sum of Squares % Contribution F-value 
p-value 
Prob > F 
A  Conc.   (M) 1642.37 10.93 298.02 <0.0001 
B  Time 1 (min) 1817.60 12.09 329.82 <0.0001 




45.39 0.30 8.24 0.0208 
AD  145.87 0.97 26.47 0.0009 
BD  0.014 9.19E-005 2.505E-003 0.9613 
ABD  415.24 2.76 75.35 <0.0001 
 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.3. Optimization via a Response Surface Model (RSM) 
Results from the factorial design above are augmented with additional points necessary 
to apply a quadratic model.  Ten additional points were needed to achieve the response 
surface in Figure 26.  The additional points were applied in a face-centered design with 
respect to the factorial model discussed above.  Additional points were then taken to 
confirm the model.  Confirmation runs were performed in triplicate (Table 9).  The 
results and model equation based on actual factors are given in Table 7. The evaluation 
of the results, as calculated by Design Expert, is given in Table 7.
 
 
Equation based on actual factors: 
%𝑦𝑖𝑒𝑙𝑑 = 73.8 + 10.7𝐴 + 9.3𝐵 + 27.6𝐷 − 10.2𝐴2 − 20.2𝐷2  
 
Table 7. Factors selected as RSM model terms based on ANOVA and associated model equation.  
Factor Description Sum of Squares F-value 
p-value 
Prob > F 
A-Concentration Temp.  (°C) 2067.46 37.36 < 0.0001 
B-Time 1 Time 1 (min) 1559.98 19.64 0.0002 





291.92 130.47 < 0.0001 
D
2
 1152.60 2.77 0.1107 
 
 






(Prob > F) 
< 0.0001 
The model is significant and there a 0.01% 
chance this F-value could be due to noise 
Std. 
Dev. 
10.26 R-Squared 0.8989 
Predicted and Adjusted R-Squared values are 
<0.2 apart, indicating the model is appropriate 
for the data collected 
Mean 54.85 Adj. R-Squared 0.8749 
CV% 18.7 Pred R-Squared 0.8247 
PRESS 3833.68 Adeq Precision 18.578 
This model can be used to navigate the design 







Figure 28 shows the published scope of materials prepared to our procedure.  Some 
examples of diaryliodonium salts that were challenging to make are presented at the 
end of this chapter and feasibility is demonstrated for a modified procedure that may 
enable access to challenging diaryliodonium salts.  
 
Figure 26. Results of optimization. The model shown has predictive value.  Triplicate 0.2 mmol scale 
confirmation runs are shown.  
 
 
Table 9. Data for confirmation runs of RSM (n=3)  
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The aryl(TMP)iodonium tosylates we have encountered have good bench stability and 
may be stored indefinitely at 4 ˚C or colder.  Compared to existing procedures, our 
method has a broader substrate scope, as good or better functional group tolerance and 
works well with elaborate iodoarenes (Figure 24: 27, 29, 30).   An unforeseen benefit of 
the tosylate group is that it readily lends itself to anion exchange (Figure 27). 
 
The procedure is scalable and has been run between 0.2 mmol and 50 mmol scale 
without noticeable effect on yield.  Starting materials that feed the development of 
diaryliodonium mediated chemistry are now more readily available and preparation 
time has been reduced from two days to less than 2 hours.  This contribution was 
recognized as a key factor in the expedient development of novel benzyne reactivity 
that was recently published by the Stuart Research Group.  Additionally, the broadened 
substrate scope of accessible diaryliodonium starting materials has enabled access to 
etherification of electron rich and elaborate arenes.  Both of these advancements are 
examples of limitations in arylation chemistry with diaryliodonium salts that are 
precedented in the literature and have now been significantly improved.  
 




2.3.5. Stability Studies 
As previously mentioned, diaryliodonium salts are used as photo-acid generators and 
will degrade rapidly upon exposure to UV light. Direct exposure to UV, including direct 
sunlight through a window will degrade many diaryliodonium salts in less than one day. 
 
Figure 28. Scope of the preparation of aryl(TMP)iodonium tosylates. min.  Scope of the preparation 
of aryl(TMP)iodonium tosylates. a Conditions: [Stage 1] aryl iodide (5 mmol), m-CPBA (5 mmol, 1 
equiv.), TsOH•H2O (5 mmol, 1 equiv.), MeCN (5 mL), 77 °C, 30 min, [Stage 2] trimethoxybenzene (5 
mmol, 1 equiv.), 5 min.  b Reaction conducted at room temperature.  c10 mmol scale of aryl iodide.  d 
30 mmol scale of aryl iodide.  e 1 mmol scale of aryl iodide.  f 20 mmol scale of aryl iodide.  
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In order to gauge their bench stability in the laboratory, a qualitative stability study was 
performed.  Samples in clear/transparent scintillation vials were placed on a window sill.  
Control samples, wrapped in aluminum foil, were placed near the window as well.  The 
control samples did not appear to be degraded upon visual inspection at any point 
during the study.  Figure 29 shows results for two aryl(TMP)liodonium salts, one with an 
electron poor arene and one electron rich.  The tosylate salts appear to be generally 
more stable than the hexafluorophosphate salts.  Thermal stability was tested using DSC 
and results are also shown in Figure 29.   
 
 
Figure 29. Light and thermal stability studies. a temperature of exothermic onset peak; b no 
exothermic onset peak noted below 200 °C; c left-hand vial left open to ambient room and 




The internal reaction temperature was also monitored in order to be aware of potential 
exothermic events, since even the possibility of a run-away reaction must be taken 
seriously.  This data was collected with an in-situ temperature probe and readings were 
manually recorded from a digital readout. Two trials were performed, one at ambient 
temperature with no heat bath and the other in a 77 °C silicone oil bath.  
 
 
Figure 30. Internal reaction temperature profiles: red x: optimized conditions; blue diamonds: 





The results are shown in Figure 30.  Note 
that the ambient temperature trial exhibits 
exothermic and endothermic events that 
are attributed to the reaction progressing 
as well as dissolution of freshly added 
reagent.  The apparatus for the ambient 
temperature reaction is shown in Figure 
31. The 77 ˚C reaction has an uneventful temperature profile and was removed from the 
heat bath at about 35 min (~2100 sec.). This indicates that a standard silicone oil bath 




Figure 32. Synthetic examples using aryl(TMB)iodonium salts.  Reactions were not optimized.  
 
Figure 31. Shot glass diaryliodonium synthesis.  
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Figure 32 shows several application examples of the aryl(TMP)iodonium salts. The 
examples underscore the wide substrate scope that diaryliodonium salts can 
accommodate.  Good to excellent yields were achieved with C-, N-, O-, S-nucleophiles. 
None of the reactions shown in Figure 32 were optimized. 
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2.5. Preparation of (4-methylbenzoate)(2ʹ,4ʹ,6ʹ-trimethoxyphenyl)iodonium 
tosylate 
With the intention of increasing awareness of diaryliodonium salts worldwide, the 
synthesis developed in Chapter 2 has been submitted to the journal Organic Synthesis.  
The purpose of this journal is to provide organic chemists with a source of 
experimentally checked procedures.  At the time of this writing, the checking process at 
Org Syn is in progress.  Dr. Katherine Liebman, an experienced researcher and synthetic 
organic chemist at Portland State University, kindly volunteered to perform the 
procedure stated below.  Both the author and Dr. Liebman carried out the procedure on 
different days, using the same equipment, and obtained pure product in 91% yield on 50 
mmol scale.  Dr. Liebman carried out this synthesis for the first time without input 
beyond the written procedure.  
 
An oil bath (Note 1) is heated to 77 °C with a digitally controlled hot-plate/stirrer, which 
is on a lab jack.  A 500-mL two-neck (24/40) round-bottom flask equipped with a Teflon-
coated magnetic stir bar (25 mm × 15 mm, elliptical) is clamped above the oil bath (Note 
2).  A jacketed, water-cooled, reflux condenser (24/40) and a powder funnel (24/40, 
glass or polypropylene) are placed on each neck of the round bottom flask as shown in 
 
Figure 33. Synthesis of the title compound 
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Figure 34A.  Methyl-4-iodobenzoate (Note 3) (13.1 g, 50.0 mmol, 1 equiv.) and p-
toluenesulfonic acid monohydrate (Note 4) (9.5 g, 50.0 mmol, 1 equiv.) are weighed out 
and transferred sequentially into the round bottom flask via the powder funnel.  
Acetonitrile (Note 5) (40 mL) is added to the round bottom flask through the powder 
funnel.  The reagents are vigorously stirred (Note 6) while still outside the oil bath 
(Figure 34B).  m-Chloroperoxybenzoic acid (Note 7) (10.7 g, 50.0 mmol, 1 equiv.) is 
weighed out and added to the round bottom flask through the powder funnel.  An 
additional 10 mL of acetonitrile is used to wash residual powder on the funnel into the 
flask.  The powder funnel is replaced with a stopper (24/40; ground glass or Teflon), 
which is secured with a Keck clip.  The lab jack is raised until the solvent line of the 
reaction is below the surface of the pre-heated oil bath (Figure 34C).  The reaction 
mixture is stirred at 77 °C (bath temperature) for 30 minutes.  A fleeting yellow color 
may develop, followed by formation of thick slurry (Figure 34C) (Note 8).    
 
 
Figure 34.  A) reaction set-up; B) addition of reagents and solvent outside the oil 
bath; C) thick slurry formed after 3 minutes at 77 °C.  
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The stopper is removed and 1,3,5-trimethoxybenzene (Note 9) (8.4 g, 50.0 mmol, 1 
equiv.) is added to the reaction via the powder funnel (Note 10).  The stopper is 
replaced on the round bottom flask, secured with a Keck clip, and the reaction is stirred 
at 77 °C for 5 minutes.  Upon addition of trimethoxybenzene, the slurry (Figure 34C) 
dissolves immediately and the homogeneous solution becomes a deep amber color 
(Figure 35A).  The lab jack is lowered and the reaction mixture is allowed to air-cool for 5 
minutes with continued stirring.  The reaction color lightens to an opaque orange upon 
cooling (Figure 35B).    
 
The reaction product, 20, is triturated from the reaction mixture by addition of diethyl 
ether (Note 11) (300 mL) and the mixture is stirred at room temperature for 15 minutes, 
during which time, an off-white precipitate forms in a light yellow mother liquor (Figure 
35C).  Product, 20, is isolated by suction filtration of the reaction mixture using a 150-
mL, medium porosity, fritted-glass funnel.  The precipitate is rinsed with diethyl ether (3 
× 40 mL) (Figure 36A).  During each rinse cycle, suction is interrupted suction, the filter 
 
Figure 35. A) reaction color observed after addition of TMB; B) reaction color 
observed after cooling reaction; C) precipitated product after trituration.  
 
51 
cake re-suspended in diethyl ether, and any clumps are broken up with a spatula before 
suction is resumed in order to remove the rinse solution (Note 12) (Figure 36B).  The 
filtrate discarded.  The product is left under suction for 5 minutes, the filter cake is 
broken up into a powder using a spatula that is left under suction for an additional 15 
minutes.  The product, 20, is obtained as a free-flowing, off-white to pale pink powder 
(27.3 g, 45.5 mmol, 91%) (Figure 36C).  The product was determined to be 97.9 wt% 
pure by qNMR (Note 13, 14, and 15).  
 
Notes & Safety: 
1. The oil bath is prepared in a crystallization dish (8 cm × 15 cm) half-filled with silicon 
oil.  
2. The round bottom flask should not be immersed in the oil bath, until indicated in the 
instructions. 
3. Methyl-4-iodobenzoate was purchased from (Oakwood, 079685, 99% used as 
received.  
 
Figure 36. A) isolation of 1 by suction filtration; B) filter cake after rinsing and re-
suspending in diethyl ether; C) final product 1.  
 
 A) reaction color observed after addition of TMP; B) reaction color
 observed after cooling reaction; C) precipitated product after trituration. 
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4. p-Toluenesulfonic acid monohydrate was purchased from (Sigma Aldrich, T35920, 
Reagent Plus ≥ 98%, used as received.  
5. Acetonitrile was purchased from VWR   
6. m-Chloroperoxybenzoic acid was purchased from (Aldrich, 273031, ≤ 77%) and dried 
under vacuum until the flask was no longer cool to touch. 
7. The stir bar will continue to agitate the reaction, no additional solvent is necessary. 
8. 1,3,5-Trimethoxybenzene was purchased from (Aldrich, 138827, ≥ 99%), used as 
received. 
9. The round bottom flask is not removed from the oil bath during addition of 1,3,5-
trimethoxybenzene.  Additional acetonitrile (up to 10 mL) may be used to wash any 
precipitate stuck to the side walls of the round bottom flask. 
10. Diethyl ether was purchased from (Fisher, ACS grade and as used as received) 
11. The diethyl ether rinse solvent can also be used to wash out the 500 mL round bottom 
flask into the filter funnel. 
12. The purity of 20 (MW 600.4; 57.8 mg) was determined by qNMR in DMSO-d6 as 
solvent and 4,4'-dihydroxybiphenyl (> 99 wt% purity; MW 186.2; 15.2 mg) as internal 
standard; the relaxation time (D1) set to 30 seconds. 
13. The remaining ~2 wt% was residual solvent (acetonitrile and diethyl ether) which we 
were unable to remove even when the sample was placed under reduced pressure. 
14. Characterization of 20: 1H NMR (400 MHz, DMSO-d6) δ 8.06 (d, J = 8.4 Hz, 2H), 7.96 (d, 
J = 8.5 Hz, 2H), 7.49 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.49 (s, 2H), 3.95 (s, 6H), 
3.88 (s, 3H), 3.86 (s, 3H), 2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.3, 165.1, 
159.4, 145.5, 137.6, 134.5, 132.0, 131.7, 128.0, 125.4, 121.0, 92.1, 86.7, 57.3, 56.1, 
52.6, 20.7.  FT-IR: 3041, 2949, 2842, 1721, 1646, 1582, 1457, 1343, 1282, 1186, 1034, 
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816 cm-1.  HRMS (ESI+): Calculated for C17H18IO5+ [M - OTs]+: 429.0193; Observed 
429.0167.  Melting point: 169-175 ˚C. 
  
54 
2.6. Future directions: Aryl(TMB)iodonium tosylates 
2.6.1. Limitations 
During the development efforts described in section 2.1 it became clear that some 
limitations exist. Figure 37 shows various diaryliodonium salts that proved to be 
challenging to make, as they failed to produce diaryliodonium salts in synthetically 
useful yield and purity. Depending on the substrate, the failure appeared to occur 
during the initial oxidation step or during installation of the auxiliary.  
 
An interesting and fortunate feature of the response surface generated during 
optimization (Figure 26) is its gentle curvature, which is taken as an indication that 
acceptable yields may be obtained even when running the reaction of lower 
temperature. For example, Figure 28 shows several examples where reaction 
 
Figure 37. Challenging substrates; stage 1: 77 ˚C, 30 min; stage 2: 77 ˚C, 5 min 
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temperature had to be lowered in order to be successful. As such, when a challenging 
substrate is encountered it is recommended that the first measure taken is to lower the 
temperature at Stage I, optionally increasing the reaction time. It was noted that 
challenging aryl substrates included functional groups prone to oxidation, like aldehydes 
and ketones. Nitrogen containing substrates are generally challenging, regardless 
whether aliphatic or aromatic, and relatively few examples exist in the literature.  
Diaryliodonium salts have been built from a few pyridyl, protected primary and 
secondary aliphatic amines as well as anilines. Another grouping of challenging 
substrates includes those that furnish a clean material in good yield with unexpected 
structure. An interesting example was observed with the ortho-nitrile, which was 
 
converted into a primary amide upon analysis of the diaryliodonium salt product.  
Proton NMR and high-resolution mass spectrometry supported this finding.  Similarly, 
iodoindole was not converted into the expected product. Interestingly, a good yield was 
achieved of a clean material with a 1H NMR spectrum that is consistent with a 
diaryliodonium salt, but not the expected product. This author expects the difficulties 
with nitrogen containing substrates are in part due to the nucleophilicity of the nitrogen 
and its state of protonation.  Examples of hypervalent iodine compounds in which 
 
Figure 38. Example of reactive ortho-positioned substrates that give unexpected products.  
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ligands are bonded to the iodine via nitrogen are well known in the literature, for 
example, Barluenga’s Reagent.  However, it seems mostly relevant that the initial 
oxidation occurs in the presence of a Bronsted acid.  It is very likely that protonation of a 
nitrogen, thus changing the ionization state to +1, will have a significant effect on 
chemical and physical properties. For example, in the case of a pyridyl or aniline 
substrate, conversion of the nitrogen into the ammonium form will inductively cause 
the substrate to become more electron deficient and potentially slow the rate of the 
oxidation step. The oxidized substrate would essentially be a dication and require two 
equivalents of the X-group. From a practical standpoint it seems very plausible that 
understanding the ionization state of nitrogen functionalities throughout the procedure 
will increase likelihood of successful workup and isolation of the target product. Of 
course, the first step would include simply adding a second equivalent of the Bronsted 
acid.  Removal of the Bronsted acid from the procedure and the feasibility of acid-free 
preparation of diaryliodonium salt will be discussed in the next section.   
Finally, certain substrates undergo reactions that seem to fail upon addition of the 
auxiliary. A control experiment showed that mCPBA and TMB react quickly and with  
release of heat.  Based on this result, it is assumed that when a diaryliodonium salt 
synthesis fails upon addition of the auxiliary, it is likely due to unexpectedly slow 
progress of the oxidation step. If the oxidation step is slow, then significant mCPBA will 
remain available to react and consume the auxiliary when it is added to the drink. From 
experience, the resulting product mixture will very likely not triturate.    
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2.6.2. Bronsted acid-free preparation of aryl(TMB)iodonium tosylate 
At some point upon entering a laboratory focused on diaryliodonium salts it is likely that 
any person will question the need for the additional protic acid during the oxidation 
step. In the academic research lab a viable work-around could be to perform slow 
addition of the oxidant and/or the auxiliary.   At the expense of increased time to install 
the auxiliary, it may also help to introduce the auxiliary in an ethyl ether solution, as the 
ethyl ether will adjust the solubility properties of the reaction and encourage any 
diaryliodonium salt to precipitate as it forms.   
In an attempt to overcome the limitations discussed in the previous section, the 
reaction was attempted using sodium tosylate in place of tosic acid.  In this formulation, 
mCPBA is initially the strongest acid with a pKa of 7.48, which is about 1 million times 
weaker then tosic acid.  The rationale for this formulation was that the oxidant 
properties of mCPBA would be attenuated.  Importantly, the reaction is not free of 
protic acid as the mCPBA is converted to its benzoic acid derivative with a pKa of about 
3.5.  The first substrate tested was 4-methyl iodobenzoate and analysis of its oxidation 
product has not been possible due to its insolubility in any solvent tested.  On visual 
inspection, the oxidation reaction appeared to progress as expected and a thixotropic 
paste was formed. The intermediate nonetheless reacted with TMB in acetonitrile.  
Because the diaryliodonium salt of this substrate is known to be soluble at 77 ˚C, it was 
expected that reacting the intermediate with TMB would result in at least part of the 
reaction going into solution. The reaction proceeded at a sluggish pace and was left to 
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reflux for one week.  Upon removal of insoluble material, evaporation of the solvent, 
and trituration with ethyl ether, the diaryliodonium salt was realized at 39% yield. Based 
on this initial result, the 3- and 4-iodoanisole substrates were reacted as shown in Figure 
39.   
 
The results in Figure 39 are encouraging because the reaction at 77 ˚C did not work with 
the iodoanisole starting substrates. The reaction conditions have been made milder 
using the conjugate base of the Bronsted acid. 
Initial attempts to prepare diaryliodonium salts from iodoaniline were not successful, 
however, formation of the product was not rigorously ruled out. That is, the product 
was not worked up with the ionization state of the aniline moiety in mind.  In such 
cases, failure of the product to triturate in ethyl ether should not be used as a 
conclusive assessment whether an iodonium salt has formed.  While feasibility of the 
 
Figure 39. a) aryl(TMP)iodonium tosylate under basic conditions. b) feasibility trials 
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method has been shown in terms of the chemistry, it is not overwhelmingly obvious 
whether the acid-free synthesis may be developed into a practicable method.  
Recommendations for future work are listed below. 
• Can product be formed without even the addition of an X-group salt? 
• How does varying the X-group salt affect the reaction and solubility of the 
intermediate? 
• What is the intermediate?  
• What is the effect of adding a Lewis acid to the oxidation product? 
The significance of the acid-free diaryliodonium synthesis could potentially go beyond 
simply expanding the substrate scope of current diaryliodonium salt preparations.  
Without Bronsted acid it is possible to envision a reaction cycle whereby a chemical 
transformation is accomplished and catalyzed by a polyvalent organoiodine reagent that 
cycles between diaryl and monoaryl species.   From the hypothetical catalytic cycle 
shown in Figure 40, it is clear that nucleophiles are required for two steps.  One of these 
serves to generate the diaryliodonium salt from the oxidized iodoarene.  The second 
nucleophile is the intended coupling partner in arylation.  Because two nucleophiles are 
present in one pot, it will be necessary for them to be orthogonal reagents.  The 
absence of acid would potentially allow the use of reagents such as the readily prepared 
aryl-boronates and aryl-silicates that have been demonstrated to impart nucleophilic 
character on the carbon atom ipso to boron or silicon.  Both of these reagents are acid 
sensitive.  Although not for arylation, Wirth has also used in-situ generation of the 
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hypervalent iodine species, using sodium perborate or a 1:1 admixture of boron 
trifluoride etherate and trimethylsilyl triflate. 33 
 
One interesting alternative would be to devise a method that electrochemically 
generates the hypervalent iodine species. The schematic in Figure 41 depicts the 
concept-design of such a process. 34 The electrolyte would be comprised of the X-group 
salt as the anode of a platinum wire.  As diaryliodonium salts are known to react non-
reversibly react at electrodes, the voltage would need to be carefully poised.  
Additionally, considerations such as pulsed current and/or switching between multiple 
working electrodes may benefit the reaction by limiting the amount of reactive 
intermediate and avoiding poisoning of the electrode surface.  
 
Figure 40. Hypothetical catalytic cycle including acid free oxidation of aryliodides 
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Anodic oxidation of iodobenzene to phenyliodine(III)bis(trifluoroethoxide)], (PIFE) has 
been reported and the oxidant solution is stable in a refrigerator for one week.35 The 
difficulty with electrochemical methods is the reoxidation, given that the reduction 
potential of iodobenzene is 1.9V, versus Ag/AgCl electrode.  Still, this does not 
conclusively demonstrate lack of potential to use electrochemistry for the in-situ 
generation of reactive intermediates in hypervalent iodine chemistry.  Very few reports 
exist on the electrochemical preparation of hypervalent organoiodine compounds and 
this area seems to be largely undiscovered.  Furthermore, it is known that reduction 
potentials may be significantly modulated depending on conditions in the 
electrochemical cell as well as by functional groups on the ring.   Electrochemical 
reactions are attractive because of the possibility to generate reactive intermediates 
that may otherwise not be possible.     
 
Figure 41. Concept for a catalytic cycle under basic conditions 
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3. An admix approach to determine the effect of the counter anion on arylation 
3.1. Introduction to the counter anion and its significance 
Diaryliodonium salts are increasingly studied for arylation of nucleophiles and the 
counter anion (X) is an important lever for reactivity.  Of the three ligands, Ar and Aux 
have been discussed in both experimental and computational reports.  Chapter 1 and 
Chapter 2 also discussed aspects of how Ar and Aux affect diaryliodonium mediated 
arylation.   However, within the context of arylation, there is little information regarding 
the influence X has on the reactivity of diaryliodonium salts. Most importantly, no 
convenient method to select a counteranion has been proposed.  It follows that this 
component of diaryliodonium salts is understudied and little information exists on how 
X potentially could interact with other reaction parameters.  It is clear from Figure 42 
that the three most commonly used X-groups including OTf, BF4 and OTs are the 
conjugate bases of the Bronsted acids called out by the three most popular 
diaryliodonium salt syntheses (see Figure 42).  
Within the context of arylation of nucleophiles proceeding through the ionic pathway, 
many reports on diaryliodonium salts include a counteranion screening study.  However 
about 25% of recent reports (2011 to 2016) we reviewed did not test more than one 
counter anion (see Figure 42, green).36   This is surprising given the potentially large 
influence counteranion identity can have on reactivity.  The data in Figure 42 give insight 
into the recent use of counteranions in diaryliodonium research.  Perhaps most striking 
is that there is no clear “best” counter anion. This supports the notion that contribution 
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of the counter anion to the progression of arylation reactions is not well enough 
understood to allow rational selection of a counter anion for a given set of reaction 
conditions. An obvious and undesirable result of the current level of understanding of 
the X-group is that efforts to study it have been heuristic.  A further complication is that 
varying the X-group for a single salt may necessitate additional development.  More 
often than not, varying the X-group is more easily accomplished by anion exchange 
rather than by varying the type of Bronsted acid used in the diaryliodonium synthesis.  
While anion exchange tends to be a simple procedure, it is sensitive to the composition 
and structure of the aryl ligands.  A particularly challenging anion exchange, for 
example, is the conversion of tosylate to acetate.  In fact, the reaction does not proceed 
without resorting to forcing conditions.  Interestingly, the exchange of tosylate into 
 
Figure 42. Counter anion use in diaryliodonium mediated arylation according to forty-two reports 
between 2011 and 2016.  
 
 




























occurrence in any study best yielding X-group only one X-group tested
64 
trifluoroacetate could be readily accomplished, while trichloroacetate required further 
method development, which is described in Section 3.10.  Importantly, development of 
a counter anion screening method will potentially improve the odds of successful 
reaction development and help diaryliodonium salts gain traction as mainstream 
arylation reagents.  If the method is also facile and practicable with small amounts of 
reagents, it would also enable study of novel, hard to access counteranions, such as the 
conjugate base of the allylic Bronsted acid, 1,1,3,3-tetratriflylpropene (TTP).  TTP was 
very recently developed by List et al and shown in Figure 43a. 37  Another recent report 
studied the effect of the counter anion on reactivity and solubility on diaryliodonium 
salts as photoinitiators of polymerization reactions.  They found one example of a 
diaryliodonium salt that exists as an oil at room temperature and therefore would 
qualify as an ionic liquid. This diaryliodonium salt was soluble even in nonpolar solvents, 
such as diethyl ether, but only when paired with the bistriflimide counter anion shown  
(Figure 43b). Importantly, almost every reported synthesis of diaryliodonium salts 
prescribes diethyl ether for trituration and washing of the product. This result is also 
intriguing simply because hypervalent iodine compounds often exhibit poor solubility in 
 
Figure 43.  a) 1,1,3,3-Tetratriflylpropene (TTP) developed by List et al. b)  Example of a 
diaryliodonium salt that is liquid at room temperature.  
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many solvents.  Diaryliodonium electrophiles often perform well in inhomogenous 
reactions, however, characterization methods that require dissolved analytes would 
certainly benefit from better solubility.  In summary, the most important requirements 
for this screening method is to overcome the need for laborious anion exchanges and to 
provide reliable results when performed on very small scale reactions.  
3.2. Feasibility of counter anion screening by the admix method 
We set out to develop a screening method and started with the literature survey shown 
in Figure 42.  According to the forty-two articles surveyed, the contribution to yield due 
to counter anion identity spans a large range. Reactions have been reported that seem 
insensitive to X-group identity. 38 On the other hand, one reaction exclusively worked in 
the presence of the acetate anion, which is one of the least often used X-groups.39  
Reported counteranion screening studies tested between 2 and 5 counteranions and on 
average the best counteranion gave a 29% higher yield than the worst, when other 
conditions were held constant.  While iodonium triflates could be seen as a frontrunner, 
there are frequent examples of other counteranions that give equivalent or better 
results.  This underscores both the potential importance of counteranion identity as well 
as the necessity for a practicable screening method.    
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3.3. Development of the salt screen 
 
The envisioned method was conceptualized according to the scheme shown in Figure 
44b.  It was envisioned that an admixed salt would insert itself into the putative 
mechanism in Figure 44b.  In theory, if in-situ anion exchange occurs and the product of 
this exchange more readily undergoes metathesis with the nucleophile, then the 
measured yield would increase relative to the reaction with no additive. On the other 
hand, if metathesis with the nucleophile is fastest with the initial diaryliodonium ion 
pair, then the yield will either be slowed or remain unaffected. Testing feasibility of 
implementation required a selection of a model reaction (Figure 45), for which we chose 
the well precedented diaryliodonium mediated azide arylation reaction.40,41  Sodium 
azide was selected as the azide source in order to avoid further complication of the 
system with additional cations. We chose to use unsymmetrical diaryliodonium salts 
bearing a trimethoxyphenyl (TMP) auxiliary for reasons discussed in Chapter 2.  A 
 
Figure 44. a) traditional salt screening, b) This work: counter anion screening by ad-mixing salt 
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convenient and economical method of screening for diaryliodonium counteranions as a 
tool for reaction and process development is presented below.  
 
Feasibility reactions were carried out similarly to the reaction in Figure 46, albeit using a 
stoichiometric amount of a sodium salt rather than an excess.   The results of these 
reactions clearly demonstrated that ad-mixing the electrophile with various sodium salts 
had a significant effect on yield.  Next, a solvent study was performed based on the 
expectation that solvent identity would affect the behavior of any salts in the reaction 
mixture.  It is well known that, depending on the solvent, the ions in solution may be 
differently stabilized, potentially impacting the reaction at hand. A rational approach 
was used for the solvent selection process and is detailed in Chapter 4. The remaining 
azidation studies included an electron-rich and an electron-poor aromatic substrate 
reacting in nine different solvents.  It was found that that acetonitrile and diglyme were 
good solvents, in that synthetically useful yields were obtained without having 
performed any optimization.   The electronically distinct substrates were also not 
sterically hindered and were included in order to observe potential interaction of ring 
electronics and the identity of the dope salt.   
 





3.4. The screening study 
 
A screening study was performed with four equivalents of dope salt and two equivalents 
of sodium azide as shown in Figure 46. The layout of the study is conceptually simple 
and is shown along with screening results. Four groupings of sodium salts were tested, 
including those based on halides, acetates, and mesylates as counteranions.  The fourth 
group can loosely be described as containing conjugate bases of fluorinated super acids.  
The data clearly showed that salt doping has an effect on azidation yield and Table 10 
highlights important results from the screening experiment.  The data used to build 
Figure 46 is available in the Supporting Information for Chapter 3. 
 
Figure 46. Salt screening method and results with 12 counter anions and two solvents. a OTs results 
are for the undoped reaction of an iodonium tosylate. b Yields were calculated from corrected 
GC/MS data relative to an internal standard (see Section 5.2.8).  
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3.5. Comparison of pre-exchanged and admixed azidation  
For this to be a viable counter anion screening method, it was also necessary to 
compare the results of doped reactions with those of pre-exchanged salts bearing the 
analogous X-group.   The results of side-by-side experiments, comparing salt-doped 
azidation reactions of diaryliodonium tosylates to those of pre-exchanged 
diaryliodonium salts, are shown in Figure 47.  The results indicate sufficient correlation 
between doped and pre-exchanged reactions and further support the use of salt 
additives as a screening method.  The reactions to which BF4 and OTf were added did 
not track well in comparison to the remaining trials.  In order to better understand these 
results, the azidation reactions were repeated with diaryliodonium tetrafluoroborate 
and diaryliodonium triflate starting materials.  In both cases, four equivalents of 
 
Table 10. Results calculated from data in Figure 46. a The average coefficient of 
variation over about one year for reactions in diglyme was 14%  (t-Bu) and 
17%(COOMe).  b the average coefficient of variation over about one year for control 
reactions (no dope salt) was 10% (t-Bu) and 9% (COOMe).  
 
Electrophile Solvent Over all range of yield
Range for reactions 
doped with the three 
most popular anions 
(OTf, BF4, OTs) 
diglyme 0% to 64% 10 % to 64%
diglyme 16% to 64% 53% to 63%
MeCN 0% to 42% 0% to 38%
MeCN 18% to 65% 35% to 63%
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common anion were added as sodium salts and the yields converged with those of the 
screening results.  
One of the more intriguing results had been increased yield obtained when sodium 
acetate was the additive in the azidation of 14.  The data for triplicate runs of the 
control reaction (yield = 66.5% ± 0.8) and the sodium acetate doped reaction (yield = 
76% ± 1.2) suggests that the means are significantly different.   This result was 
unexpected as, in our hands, exchanging tosylate for acetate has not been possible 
without first converting to a halide and then forcing the exchange with silver acetate.   
Unfortunately, the beneficial effect of adding acetate was not repeated during 
optimization.  During optimization it was observed that addition of acetate had no 
statistically significant effect on yield.  The conflicting results observed with acetate 
doping were taken as a welcome reminder that when assessing replicate results, day-to-
day variation must be considered.  As previously mentioned, the S/N value is key in 
objectively assigning a change in output to any effect.   Interestingly, Table 10 points out 
that the coefficient of variation calculated from about one year’s worth of the control 
reaction with 14 was 10%.  Because of this variation in the longer term data, a more 
rigorous assessment would be needed in order to more confidently make any 
conclusions regarding the effect of acetate anion on azidation of 14.  Nonetheless, the 
often close correlation of doped to pre-exchanged yield results, points to the possibility 







Figure 47.  Comparison of azidation yields for iodonium tosylate doped with NaX, pre-exchanged 
diaryliodonium salts, and pre-exchanged diaryliodonium salts admixed with 4 equiv. of 
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COOMe - with ad-mixed 4 equiv. NaX
COOMe - pre-exchanged X-group




3.6. Scope of the screening method 
We then moved on to test the general applicability of salt doping as a primary screen by 
adapting reported reactions to be compatible with salt doping.  Care was taken to follow 
the literature procedures as closely as possible.42 Figure 48 shows that upon normalizing 
results to 100%, we observed significant correlation between our results.  These results 
not only demonstrated the applicability of salt-doping as primary screen, but also 
demonstrate its practicality by using only one diaryliodonium starting material (see 
Figure 46).   
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3.7. Optimization and some azidation examples 
 
 
Figure 48. Selected counteranion studies from the literature are shown and compared to our results 
using the reported preparations adapted to our salt doping method.  a yield values have been scaled 
to a 100%. 
 
Figure 49. Optimization of the aryl azidation reaction.  
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Optimization was performed with the more electron rich substrate as shown in Figure 
48. The tosylate was selected as the best X-group for the azidation reaction and the 
reaction was optimized.  The DoE workflow, presented in Figure 16, was again followed.  
A full factorial design was performed to study the effect on azidation yield of 
temperature, equivalents of sodium azide, and the presence or absence of sodium 
acetate in the reaction.   There was no statistically significant difference in reaction yield 
whether or not sodium acetate was included.   The optimization was continued with two 
factors, temperature and azide-stoichiometry, in order to generate the quadratic model 
described by the contour plot below (Figure 50).  The graph below nicely shows the 
importance of interaction effects, which are clearly present between the factors, 
temperature and azide concentration.  A chemist using the OVAT method may 
reasonably decide to study the effect of azide concentration.  The importance of azide 
concentration may be overlooked if the reaction were to be run below around 40 °C, 
because the contour lines are nearly parallel to the ordinate.  If azide concentration is 
deemed to have little effect, then temperature would likely be studied next.  However, 
the two hour reaction using 2 equivalents of sodium azide will reach its maximum yield 
of about 70% at 64 °C.  The take home message is that DoE can provide high quality data 
in relatively few experiments as compared to the OVAT method.   
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With optimization complete, several azidations were performed in order to 
demonstrate the substrate scope of the reaction with aryl(TMP)iodonium tosylates.  A 
variety of functional groups were tolerated, including a pyridyl, a phenethyl alcohol and 
one elaborate arene (Figure 51).  The experimental details may be found in the 




Figure 50. Optimization of azidation.  Contour plot with confirmation runs.  Note that varying 
either factor independently would not have allowed the maximum yield conditions to be 
located 
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3.8. Discussion of unexpected BF4 and OTf doping results 
According to the putative mechanism shown in Figure 8, it is generally assumed that 
formation of the transition state immediately preceding reductive elimination comprises 
the rate limiting step.  More specifically, displacement of the counteranion by a 
nucleophile is not commonly considered as influential over the reaction yield and the 
product distribution.   However, this is not entirely consistent with our observations, 
that upon adding excess common anion, as in the case of BF4 and OTf salts, the yield of 
aryl azide was reduced.  The reduced yield was clearly related to addition of excess 
common anion and GC/MS data did not indicate any appreciable change in 
chemoselectivity and no unexpected products were observed.  A series of experiments 
was performed in order to collect more complete data regarding the effect of the added 
 
Figure 51. Representative scope of aryl azide compounds synthesized.  
aConditions: 1-OTs (0.1-0.5 mmol, 1 equiv.), NaN3 (0.65-3.25 mmol, 6.5 equiv.), 
diglyme (1-5 mL), 65 °C, 2 hours.  b Reaction conducted on 1.0 mmol scale of 1-
OTs.  c Reaction performed in acetonitrile.  
77 
common anion on reaction yield.  A common characteristic of diaryliodonium salts is 
their poor solubility, which often results in inhomogenous reaction mixtures.  Addition 
of an excess of the common anion should force precipitation of the diaryliodonium salt 
according to its solubility product. It was assumed that metathesis between the 
nucleophile and the counter anion could not occur while the diaryliodonium salt is 
precipitated. However, while working on a related project, to develop a rapid and 
scalable counter anion exchange method (Section 3.10), it seemed that anion exchange 
is possible so long as one of reactants is soluble.  It was observed that if a 
diaryliodonium tosylate is eluted through a plug of granulated salt (NaX), then ion 
exchange occurs during the course of elution and solid sodium tosylate is presumably 
left behind.  It seems reasonable that this would likely also apply to ionic nucleophiles 
participating in inhomogeneous reactions.  Furthermore, the data shown in Figures 53, 
54 and 55 show an unexpected increase in yield when roughly one equivalent or less of 
the dope salt is added.  Based on these observations, two additional considerations 
potentially become relevant.  Firstly, a change in ionic strength of the reaction medium 
due to addition of some amount of salt is a reasonable possibility.  Secondly, aside from 
simply precipitating, the common ion effect could also influence unknown equilibria 
that exist due to secondary interactions between dissolved diaryliodonium salts. This 
concept was also suggested by a group studying polymerization reactions using 
diaryliodonium salt initiators (Figure 52).  They found that conductivity correlated with 
polymerization rate, which should be proportional to the rate at which the 
diaryliodonium salt transforms into an active initiator.  Of particular note, the 
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polymerization rate and the conductivity did not correlate with the solubility of the 
iodonium salts under study. 
 
Reaction stoichiometries were studied in more detail and some noteworthy results were 
obtained.  The importance of these experiments is that they directly study the possible 
effect of salt equilibria on the azidation reaction.  While further study beyond the 
figures below has not been possible, the data does seem to be consistent with the 
notion that more than one mechanism is influencing the azidation reaction.  Without 
replicating these results and further study, it is difficult to say more.  The data is quite 
compelling in that it could indicate that the metathesis step is a stronger lever for 
reaction yield that is traditionally believed.  
 
Figure 52.  Proposed processes that could limit availability of diaryliodonium salts for reaction even 
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Figure 56.  Yield is plotted as a function of the ratio tosylate to azide as both are varied.  Total 
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3.9. Spectator salt or in-situ anion exchange? 
NMR studies were conducted in an attempt to better understand the chemical 
processes that are affected by changes in counter anion identity.  Because of the limited 
solubility of diaryliodonium salts, solvents could not be varied and DMSO-d6 was used 
for the majority of NMR experiments.   
After rigorous assignment of chemical shifts for proton and carbon NMR spectra, peak 
shifts were analyzed for changes that could be correlated to counter anion identity (see 
Supporting Information).  As expected, the ipso-carbon signals corresponding to both 
iodine-arene bonds are affected by counter anion identity.  The greatest differences 
were noted among the halide anions (Figure 59). Also, exchanging trifluoroacetate for 
acetate resulted in a significant deshielding of the ipso-carbons in a diaryliodonium salt 
with a TMP auxiliary (Figure 59). 
An interesting, observation occurred when tetrabutylammonium chloride was added to 
the NMR solution of diaryliodonium salts with either the TMP or the Mes auxiliary.  The 
Mes salt is significantly more sterically 
encumbered than TMP.  Further, being alkyl 
substituted, Mes is electron rich, however, not 
to the same extent as TMP (Figure 57). 
Considering the trans-influence, TMP would be 
the more σ-donating of the two auxiliaries and 
 
Figure 57. Diaryliodonium salts with  
























































































































































































































































so more destabilizing to the X-group, which is the assumed trans-ligand.  The hypothesis 
was that adding chloride anion to an NMR so lution of diaryliodonium tosylate would 
effect a counter anion exchange and that depending on the chloride concentration the 
ipso-carbon peaks in the 13C NMR spectrum should converge on the shift of the neat 
diaryliodonium chloride.  In fact, this was observed when an NMR solution of 
aryl(mesityl)iodonium tosylate was exposed to chloride anion (Figure 59).  However, 
when the same experiment was performed with an aryl(TMP)iodonium tosylate, the 
expected shift did not occur and instead the ipso-carbon peaks in the 13C NMR spectrum 
became increasingly broadened with increasing chloride concentration (Figure 58a).  
Upon adding up to a four-fold excess of chloride anion, the peaks do clearly indicate 
conversion to the chloride salt.  However, a puzzling feature of the 13C NMR scans of the 
aryl(TMP)iodonium tosylate is that even at half an equivalent added chloride, the ipso-
carbon peaks are no longer appreciable.  The peaks that are visibly affected with 
increasing chloride concentration were assigned to the Ar-group and not the Aux-group 
(see Figure 58b).  
These recent findings could potentially be explained by a difference in the ground-state 
stability when using either a TMP or Mes auxiliary. More specifically, the TMP auxiliary is 
by far the most electron-rich of any of the arenes that were part of this experiment and 
so should exert the largest trans-influence on the trans-ligand bound to iodine. It is 
conceivable that the larger trans-influence of TMP and its lack of steric bulk allow it to 
spend more time in the axial position.   If this is the case, then association of any X-
group in solution with the iodine may be destabilized and the result could be a rapid 
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equilibrium between associated and dissociated states.  Additionally, the shifting peaks, 
“c” and “d” are assigned to the Ar-group and the peaks, “h” and “g” are unchanged and 
assigned to the tosylate group.  This indicates that whatever change is occurring is due 











3.10. Rapid anion exchange method 
 
Several anion exchange methods exist for diaryliodonium salts. Figure 61a shows the 
anion exchange method preferred in this document as it usually avoids extractions, is 
facile and often removes trace impurities.   Several authors report anion exchanges by 
first dissolving the diaryliodonium salt into 
dichloromethane or chloroform and then 
vigorously mixing the solution with a saturated 
solution aqueous solution bearing the target 
anion.  This, DCM-extraction method, often 
results in emulsions and messy extractions and is 
poorly suited for scale-up.  The method in Figure 
61a is superior because extractions are usually 
not needed.  Nonetheless a more rapid method is 
desirable if preparing many different types of 
 
Figure 61. Anion exchange from tosylate a) basic aqueous salt exchange process;  




Figure 62. Ion exchange columns are 








salts.  Based on observations of the anion exchange process, it was noticed that both 
components may not necessarily need to be  substantially in solution in order to 
undergo anion exchange.  In fact, precedent for this exists with ion exchange resins that 
undergo metathesis with an eluent.  
 
The work in this section simply describes the feasibility demonstration of an anion 
exchange method that functions by elution of a dissolved diaryliodonium salt through a  
column packed with a sodium salt comprised of the target anion.  Immediately, it 
became clear that each different substrate will require some amount of development as 
 
Figure 63. Scope of currently tested salts exchanged using the elution method.  
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the method is somewhat finicky.  For example, while exchanging tosylate for TFA, the 
rate of elution of a diaryliodonium-methanol solution was found to quickly diminish to 
the point that the liquid could not be eluted with pressure nor with suction.  This 
clogging was assumed to occur as sodium tosylate fines precipitated within the column.  
The solution was to include a filter-aid in the column packing.  Celite and coral sand both 
worked as filter aids, with coral sand being superior.  In this way, some mindfulness and 
attention to engineering solutions may be necessary for certain salts to be anion 
exchanged by this method.  When the method works, however, several milimol of 
diaryliodonium salt may be exchanged within minutes, plus the time to remove the 
solvent.   Figure 63 shows that excellent conversion was achieved for several different 
starting diaryliodonium tosylate salts. These salts could be anion exchanged in moderate 
 
Figure 64. Feasibility study for re-use of anion exchange cartridge 
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to excellent yield, using a scalable process, in less than 10 minutes, which would 
previously take at least 2 hours.  Finally, the columns were fabricated from plastic  
syringes and based on feasibility experiments in Figure 64 they are reusable.  Based on 
the reusability and scalability of this method it is likely that one such cartridge, or 
column would last a research laboratory months.  A particularly time saving experiment 
was realized when diaryliodonium tosylate was eluted through a layer of bromide salt 
followed by a layer of a silver acetate or silver tetrafluoroborate salt.  By using layers of 
solid salts it was possible to exchange tosylate into acetate, which normally takes 
several steps and is laborious.  As such this was a successful side project. 
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4. Details on solvent selection: use of Hansen Solubility Parameters 
Solvents for the azidation reactions presented in Chapter 3 were selected based on their 
Hansen Solubility Parameters (HSP).  Briefly, HSP are an improvement on the 
Hildebrandt solubility parameter, which was based on the idea that the enthalpy of 
vaporization of a solvent is a function of the affinity between solvent molecules.  Dr. 
Charles Hansen further developed the Hildebrand parameter by suggesting that the 
affinity between solvent molecules is the combination of dispersion, polar, and 
hydrogen bonding forces.  Using these three parameters Hansen empirically determined 
and published the HSP values for thousands of small molecules and polymers.   The 
concept and practical utility of HSP is easily visualized if the three parameters are used 
as the axes on a 3D graph.  By empirically determining the limit of solubility of an 
analyte on each axes one can estimate its HSP values.  A molecule will be readily soluble 
when mixed in a solvent with similar HSP.   
In this case, HSP were used to select solvents with the intention of adequately 
representing the possible solvent space.  Ideally, nine readily available solvents would 
be selected so that their HSP would form a cube with a center point in HSP space.   It 
was quickly obvious that at best the solvents selected would resemble some very 
distorted polyhedron comprised of 8 vertices and a point somewhere within its volume. 
The solvents were additionally cross-referenced against principal component analysis 
values (PCA) reported by Rolph Carlson. 43 The PCA analysis is not trivial and includes 
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numerous parameters.   The solvents selected for our study were found to adequately 
represent the solvent space according to both HSP and Carlson’s PCA analysis.   
The azidation reactions in Figure 45 were performed using one electron rich and one 
electron poor aryl(TMP)iodonium tosylate.  Table 12 shows the azidation yield for each 
solvent as well as the HSP values and fractional HSP values.   
 
Fractional HSP values simply are the geometric average of the standard HSP values. For 
example, the fractional dispersion parameter of pentane is found by taking the ratio of 
the regular dispersion HSP value and sum of all three regular HSP values. The fractional 
polar and hydrogen bonding parameters may be calculated the same way. The fractional 
values allow the reaction yields from Table 12 to be shown as contour lines on the 
ternary diagrams in Figure 65 and Figure 66. 
solvent Disp Polar H-bond D% P% H% tBu %yield 
COOMe 
%yield 
pentane 14.5 0.0 0.0 100% 0% 0% 0 0 
water 15.6 16.0 42 21% 22% 57% 2 1 
toluene 18.0 1.4 2.0 84% 7% 9% 12 7 
Ethylene Glycol 16.0 12.0 20.0 33% 25% 42% 20 29 
1,4 dioxane 19.0 1.8 7.4 67% 6% 26% 39 24 
Dichloroethane 19.0 7.4 4.1 62% 24% 13% 37 28 
Ethanol 15.8 8.8 19.4 36% 20% 44% 42 25 
Acetonitrile 15.3 18.0 6.1 39% 46% 15% 30 41 
propylene 
carbonate 
21.0 18.0 6.1 47% 40% 14% 32 41 
diglyme 16.2 7.8 12.6 44% 21% 34% 45 41 
Table 11. Solvent screening for aryl azidation using HSP and fractional HSP.  Unoptimized 





Figure 65. Solvent effect on azidation of 4-tertbutyl iodobenzene. Ternary contour plots of yield vs. 













Figure 66. Solvent effect on azidation of 4-methyl iodobenzoate. Ternary contour plots of yield vs. 




index D% P% H% 
a 46 20 34 
b 43 22 35 
c 47.5 26.5 26 
d 44 28 28 
average 45 24 31 
Table 12.  The coordinates for the vertices of the area of maximum yield on both Figure 65 and 







The area of maximum yield shared by the ternary plots in Figure 65 and Figure 66 is 
bounded by the coordinates that correspond to the fractional HSP listed in Table 13.  A 
particularly useful aspect of HSP is that they are additive according to mole fraction.  
That is, if two or more hypothetical, miscible, solvents are mixed then the HSP of the 
mixture may be calculated according to the new solvent systems composition. Similarly, 
Table 12 shows the average fractional HSP that correspond to maximum yield can be 
used to look up a solvent with the closest matching HSP. Based on the results shown in 
the two ternary diagrams, it is clear that parameters such as HSP have potential for use 
as inputs to experiment designs.  This sets the framework for future studies that use 
physicochemical properties as inputs to experiment designs, thus studying the chemistry 
directly and not just the effect of reaction conditions.   
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5. Supporting Information 
5.1. General information for all Supporting Information herein. 
Materials.  Commercially available reagents and solvents were used without further 
purification unless otherwise stated.  m-CPBA was purchased from Sigma-Aldrich, dried, 
and assayed by iodometric titration before use according to literature procedures.44  
Starting materials for Figure 51 45, 14-TFA 46 , 52 47 were prepared to previously reported 
procedures.4'-iodo-[1,1'-biphenyl]-4-carbonitrile48 and 2-(4-iodobenzyl)isoindoline-1,3-
dione49 was prepared according to literature procedure.  All other materials were 
prepared as described in detail below.   
Methods.  Reactions were performed in borosilicate, Teflon-lined, screw-cap vials or 
round bottom flasks without exclusion of ambient air or moisture, unless otherwise 
stated.  Reactions heated above room temperature were done in an aluminum block or 
oil bath, heated externally by a digitally controlled hotplate/stirrer.  Solvents were 
removed by rotary evaporation.   
Proton (1H), carbon (13C) and fluorine (19F) nuclear magnetic resonance (NMR) spectra 
were recorded using a Bruker AVANCE III spectrometer with a 9.4 T magnet, 5 mm BBO 
probe and operating at 400.13 MHz.  If indicated, a Bruker Avance III with 5mm PATXI 
probe, operating at 599.88 MHz, was used.  Each spectrum shown below was recorded at 
298 K in DMSO-d6 or CDCl3.  Chemical shifts in proton and carbon spectra are referenced 
to the tetramethylsilane (TMS) signal.  Multiplicity is given as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, dq = doublet of quartets, m = multiplet.  NMR yields were 
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determined from 1H NMR spectra of crude reaction products using anhydrous 
dimethylformamide (ACROS, 99.8%) as an internal standard.   
Thin layer chromatography (TLC) was performed using plastic-backed silica gel plates 
(Silicagel 60 Å, F-254) and visualization was accomplished using ultraviolet light (254 nm).  
Flash column chromatography was performed on SiliCycle silica gel, (SiliaFlash, P60, 40-
63 μm, 60Å).  
 
FT-IR spectroscopy was performed on a ThermoScientific, Nicolet iS5 spectrometer in 
transmission mode, using OMNIC software, version 9.2.98.  Samples were dissolved in 
dichloromethane, applied to a salt plate and the solvent allowed to evaporate.  
 
Molecular weight determinations were made on a ThermoElectron, LTQ-Orbitrap, high 
resolution mass spectrometer with dedicated Accela HPLC system and electrospray 
ionization (ESI).  High resolution MS of compound S1 was obtained from the Oregon State 
University, Mass Spectrometry Facility and used a Water Synapt G2 coupled to Agilent 
APGC.  Low resolution molecular weight determinations were made using an Agilent 5973 
GC-MS system, using EI.   
 
Melting point (mp) measurements were recorded using Mel-Temp instruments and 
reported as uncorrected values.  Melting point samples were taken from the product 
produced to the following procedures without further purification. 
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5.2. Supporting Information for Chapter 2 
5.2.1. General procedure for the synthesis of aryl(TMB)iodonium tosylates 
Aryl iodide (5 mmol, 1 equiv.) and acetonitrile (5 mL) were added to a 50 mL round-
bottom flask, equipped with a magnetic stir bar.  Toluenesulfonic acid (5.05 mmol, 1.01 
equiv.) was added in one portion, followed by one portion of m-CPBA (5.05 mmol, 1.01 
equiv.).  After attaching a reflux condenser, the reaction was lowered into an oil bath set 
to 77 °C and stirred vigorously.   After 30 minutes, the reflux condenser is removed in 
order to add (5.05 mmol, 1.01 equiv) 1,3,5-trimethoxybenzene (TMB) in one portion and 
stirring was continued at 77 °C for 5 minutes.  The reaction was removed from heat and 
concentrated under reduced pressure.  The crude residue was triturated with diethyl 
ether.  The precipitate was isolated by vacuum filtration and washed by slurry filtration 
with diethyl ether (3 × 20 mL).  After drying under high vacuum the diaryliodonium salt 
was obtained in analytically pure form.  
 
5.2.2. Characterization data for aryl(TMB)Iodonium tosylates  
Compound 11 – Prepared according to the general procedure above on 10 mmol scale 
and obtained in 96% yield (5.353 g) as an off-white powder.  1H NMR 
(400 MHz, DMSO-d6) δ 7.83 – 7.75 (m, 2H), 7.52 – 7.45 (m, 2H), 7.25 
(d, J = 8.1 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.45 (s, 2H), 3.94 (s, 6H), 
3.86 (s, 3H), 2.30 (s, 3H), 2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) 
δ 166.0, 159.3, 145.5, 141.8, 137.6, 134.3, 132.0, 128.0, 125.4, 112.4, 91.9, 87.2, 57.2, 
56.1, 20.7 (one carbon signal unaccounted for due to overlapping methyl signals).  FT-IR: 
3023, 1642, 1585, 1458, 1414, 1207, 1185, 1035, 816 cm-1. HRMS (ESI+): Calculated for 
C18H18IO3+ [M - OTs]+: 385.0295; Observed 385.0265.  Mp decomposed 168 C̊. 
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Compound 12 – Prepared according to the general procedure above with the exception 
of running both stages at room temperature.  The 5 mmol scale 
reaction yielded 85% (2.621 g) as a white powder.  1H NMR (400 
MHz, DMSO-d6) δ 7.92 – 7.87 (m, 2H), 7.54 – 7.44 (m, 4H), 7.10 (d, 
J = 7.8 Hz, 2H), 6.45 (s, 2H), 4.70 (s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 
2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.0, 159.2, 145.4, 141.5, 137.6, 134.6, 
132.0, 128.0, 125.4, 115.8, 91.9, 87.7, 57.2, 56.1, 32.7, 20.7.  FT-IR: 3090, 3033, 2978, 
2945, 2844, 1643, 1583, 1413, 1186, 815, 682, 565 cm-1. HRMS (ESI+): Calculated for 
C16H17BrIO3+ [M - OTs]+: 462.9400 Observed 462.9383.  Mp decomposed 157 C̊ 
Compound 13 – Prepared according to the general procedure above on 5 mmol scale with 
the following deviations: i) Stage 1 was run at ambient 
temperature, ii) stage 2 was run at ambient temperature, iii) Stage 
2 reaction progress was assessed by TLC and Stage 2 reaction time 
was one hour.  The product was isolated in 87% yield (2.49 g) as a 
white powder.  1H NMR (400 MHz, DMSO-d6) δ 7.87 (d, J = 8.4 Hz, 2H), 7.48 (d, J = 8.1 Hz, 
2H), 7.38 (d, J = 8.4 Hz, 2H), 7.10 (d, J = 7.9 Hz, 2H), 6.45 (s, 2H), 5.50 – 5.25 (br. s, 1H), 
4.52 (s, 2H), 3.94 (s, 6H), 3.85 (s, 3H), 2.27 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.0, 
159.2, 146.5, 145.4, 137.6, 134.1, 129.1, 128.0, 125.4, 113.6, 91.9, 87.2, 61.9, 57.2, 56.0, 
20.7.  FT-IR: 3410, 3080, 3033, 2995, 2918, 2852, 1644, 1572, 1443, 1412, 1340, 1040, 821 
cm-1. HRMS (ESI+): Calculated for C16H18IO4+ [M - OTs]+: 401.0244; Observed 401.0219.  Mp 
184-186 ˚C 
Compound 14 – Prepared according to the general procedure above on 10 mmol scale 
and obtained in 93% yield (5.570g) as a white powder.  1H NMR (400 
MHz, DMSO-d6) δ 7.87 – 7.80 (m, 2H), 7.53 – 7.44 (m, 4H), 7.10 (d, J 
= 7.8 Hz, 2H), 6.47 (s, 2H), 3.96 (s, 6H), 3.87 (s, 3H), 2.28 (s, 3H), 1.23 
(s, 9H).  13C NMR (101 MHz,  MSO) δ 166.0, 159.3, 154.5, 145.6, 
137.5, 134.1, 128.5, 128.0, 125.4, 112.6, 91.9, 87.0, 57.3, 56.1, 34.7, 
30.6, 20.7.  FT-IR: 3071, 2953, 2867, 2840, 1036, 1634, 1583, 1467, 
1412, 1208, 1125, 815 cm-1. HRMS (ESI+): Calculated for C19H24IO3+ [M - OTs]+: 427.0765; 
Observed 427.0746.  Mp 190-192 ˚C 
Compound 15 – Prepared according to the general procedure above on 5 mmol scale with 
the following deviations: i)in Stage 2, mesitylene was added in 
place of TMB, ii) Stage 2 reaction time was  six hours and 
reaction progress was monitored by TLC.  The product was 
obtained in 84% yield (2.303g) as a white powder.  1H NMR (400 
MHz, DMSO-d6) δ 7.88 (d, J = 8.7 Hz, 2H), 7.49 (d, J = 8.7 Hz, 2H), 
7.46 (d, J = 8.1 Hz, 2H), 7.19 (s, 2H), 7.09 (d, J = 7.9 Hz, 2H), 2.60 
(s, 6H), 2.28 (s, 6H), 1.23 (s, 9H). 13C NMR (101 MHz, DMSO-d6) δ 154.6, 145.4, 142.8, 
141.4, 137.5, 134.1, 129.6, 128.8, 127.9, 125.4, 122.6, 111.0, 34.7, 30.6, 26.2, 20.7, 20.4.  
FT-IR: 3090, 3062, 3039, 2965, 2871, 2843, 1640, 1393, 1214, 1187, 816 cm-1. HRMS (ESI+): 
Calculated for C19H24I+ [M - OTs]+: 379.0917; Observed 379.0895.  Mp decomposed 175 ˚C 
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Compound 16 – Prepared according to the general procedure above on 5 mmol scale with 
the following deviation: i) in Stage 2, thiophene was used in place 
of TMB. The product was obtained in 71% yield (1.186g) as a white 
powder.  1H NMR (400 MHz, DMSO-d6) δ 8.20 – 8.13 (m, 2H), 8.11 
– 8.05 (m, 1H), 7.99 – 7.92 (m, 1H), 7.57 – 7.44 (m, 4H), 7.17 – 7.07 
(m, 3H), 2.28 (s, 3H), 1.23 (s, 9H).  13C NMR (101 MHz, DMSO-d6) δ 
154.9, 145.1, 140.2, 137.8, 137.0, 134.3, 129.4, 128.6, 128.0, 125.4, 115.8, 100.7, 34.7, 
30.6, 20.7.  FT-IR: 3094, 3059, 2962, 2927, 2867, 1652, 1392, 1214, 1188, 1032, 816 cm-1. 
HRMS (ESI+): Calculated for C14H16IS+ [M - OTs]+: 343.0012; Observed 342.9998. Mp 125-
136 ˚C 
Compound 17 – Prepared according to the general procedure above on 5 mmol scale with 
the following three deviations: i) in Stage 2, anisole was used 
in place of TMB, ii) Stage 2 reaction time was one hour and 
reaction progress was assessed by TLC; iii) the solvent was 
not removed from the crude reaction and instead 
immediately triturated with ethyl ether.  The product was 
filtered and washed according to the general procedure and 
obtained in 84% yield (2.250g) as a white powder 1H NMR (400 MHz, DMSO-d6) δ 8.24 – 
8.17 (m, 2H), 8.16 – 8.10 (m, 2H), 7.56 – 7.51 (m, 2H), 7.50 – 7.45 (m, 2H), 7.12 (d, J = 7.9 
Hz, 2H), 7.06 – 7.01 (m, 2H), 3.77 (s, 3H), 2.28 (s, 3H), 1.23 (s, 9H).  13C NMR (101 MHz, 
DMSO-d6) δ 161.7, 154.7, 145.5, 137.6, 137.2, 134.6, 128.5, 128.0, 125.5, 117.2, 113.5, 
105.4, 55.6, 34.7, 30.6, 20.7.  FT-IR: 3091, 3061, 3050, 2963, 2902, 2869, 2840, 1395, 1254, 
1184, 817 cm-1. HRMS (ESI+): Calculated for C17H20IO+ [M - OTs]+: 367.0553; Observed 
367.0528 Mp 177-180 ˚C 
Compound 18 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 93% yield (2.520 g) as a white powder.  1H NMR (400 MHz, 
DMSO-d6) δ 7.92 (d, J = 7.5 Hz, 2H), 7.64 – 7.38 (m, 5H), 7.10 (d, J = 7.5 
Hz, 2H), 6.47 (s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 2.27 (s, 3H).  13C NMR (101 
MHz, DMSO-d6) δ 166.1, 159.3, 145.5, 137.6, 134.2, 131.4(2), 131.3(6), 
128.0, 125.4, 116.0, 92.0, 87.0, 57.2, 56.1, 20.7.  FT-IR: 3041, 2949, 2842, 2842, 1721, 
1646, 1582, 1457, 1343, 1282, 1186, 1034, 816 cm-1. HRMS (ESI+): Calculated for 
C15H16IO3+ [M - OTs]+: 371.0139; Observed 371.0121.  Mp decomposed 167 C̊. 
Compound 19 – Prepared according to the general procedure above on 10 mmol scale 
and obtained in 90% yield (5.533g) as an off-white powder.  1H 
NMR (400 MHz, DMSO-d6) δ 7.99 (d, J = 8.6 Hz, 2H), 7.74 (d, J = 8.6 
Hz, 2H), 7.70 – 7.62 (m, 2H), 7.56 – 7.32 (m, 5H), 7.10 (d, J = 7.9 Hz, 
2H), 6.49 (s, 2H), 3.97 (s, 6H), 3.88 (s, 3H),  2.27 (s, 3H).  13C NMR 
(101 MHz, DMSO-d6) δ 166.1, 159.3, 145.6, 143.1, 138.1, 137.5, 
134.8, 129.5, 129.0, 128.5, 128.0, 126.9, 125.4, 114.5, 92.0, 87.0, 57.3, 56.1, 20.7.   FT-IR: 
3089, 3068,2967, 2943, 2878, 2839, 1646, 1586, 1468, 1339, 1209, 1033, 816, 765, 684 
100 
cm-1. HRMS (ESI+): Calculated for C21H20IO3+ [M - OTs]+: 447.0452; Observed 447.0431. 
Mp 162-164 ˚C 
Compound 20 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 93% yield (2.52 g) as a pale yellow powder.  1H NMR 
(400 MHz,  MSO) δ 8.06 (d, J = 8.4 Hz, 2H), 7.96 (d, J = 8.5 Hz, 
2H), 7.49 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.49 (s, 2H), 
3.95 (s, 6H), 3.88 (s, 3H), 3.86 (s, 3H), 2.28 (s, 3H).  13C NMR (101 
MHz,  MSO) δ 166.3, 165.1, 159.4, 145.5, 137.6, 134.5, 132.0, 
131.7, 128.0, 125.4, 121.0, 92.1, 86.7, 57.3, 56.1, 52.6, 20.7.  FT-
IR: 3041, 2949, 2842, 1721, 1646, 1582, 1457, 1343, 1282, 1186, 1034, 816 cm-1.  HRMS 
(ESI+): Calculated for C17H18IO5+ [M - OTs]+: 429.0193; Observed 429.0167.  Mp 169-175 C̊.  
Compound 21 – Prepared according to the general procedure above on 30 mmol scale 
and obtained in 90% yield (16.527 g) as a white powder.  1H NMR 
(400 MHz, DMSO-d6) δ 8.13 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.4 Hz, 
2H), 7.52 – 7.43 (m, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.50 (s, 2H), 3.96 
(s, 6H), 3.89 (s, 3H), 2.29 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 
166.4, 159.4, 145.5, 137.6, 135.0, 131.3 (q, JC-F = 32.4 Hz), 128.1 (q, 
JC-F = 3.5 Hz), 128.0, 125.4, 123.4 (q, JC-F = 272.8 Hz), 120.3 (br. s), 92.1, 87.0, 57.3, 56.2, 
20.7.  19F NMR (376 MHz, DMSO-d6) δ -61.6.  FT-IR: 3090, 2979, 2847, 1467, 1644, 1584, 
2949, 1414, 1210, 1182, 1034, 816 cm-1. HRMS (ESI+): Calculated for C16H15F3IO3+ [M - 
OTs]+: 439.0013; Observed 438.9989.  Mp 167-170 ˚C. 
Compound 22 – Prepared according to the general procedure above on 1 mmol scale and 
obtained in 75% yield (0.428 g) as a pink powder.  1H NMR (400 MHz, 
DMSO-d6) δ 8.45 (dd (appears as triplet), J = 1.5 Hz, 1H), 8.22 – 8.17 (m, 
1H), 8.10 – 8.03 (m, 1H), 7.65 (dd (appears as triplet), J = 8.0 Hz, 1H), 7.47 
(d, J = 8.1 Hz, 2H), 7.11 (d, J = 7.9 Hz, 2H), 6.48 (s, 2H), 3.95 (s, 6H), 3.88 
(s, 3H), 2.29 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.3, 159.3, 145.4, 
138.8, 137.6, 137.3, 135.2, 132.2, 128.0, 125.4, 116.9, 116.1, 113.6, 92.0, 
87.1, 57.3, 56.1, 20.7.  FT-IR: 3088, 2946, 2846, 2232, 1647, 1583, 1468, 1413, 1229, 1187, 
1035, 785 cm-1. HRMS (ESI+): Calculated for C15H15INO3+ [M - OTs]+: 396.0091; Observed 
396.0076.  Mp 175-178 ˚C. 
Compound 23 – Prepared according to the general procedure above on 5 mmol scale with 
the following exceptions: i) the reaction was removed from the heat 
bath for 10 minutes before starting Stage 2, ii) Stage 2 was run for 10 
minutes at room temperature.  The product was obtained in 81% 
yield (2.478 g) as a light pink powder. 1H NMR (400 MHz, DMSO-d6) 
δ 7.95 (d, J = 1.8 Hz, 2H), 7.83 (s, 1H), 7.48 (d, J = 8.0 Hz, 2H), 7.11 (d, 
J = 7.9 Hz, 2H), 6.50 (s, 2H), 3.97 (s, 6H), 3.89 (s, 3H), 2.29 (s, 3H).  13C 
NMR (101 MHz, DMSO-d6) δ 166.5, 159.4, 145.3, 137.7, 135.5, 132.1, 131.4, 128.0, 125.4, 
116.6, 92.1, 87.3, 57.3, 56.2, 20.7.  FT-IR: 3067, 3037, 2980, 2959, 2939, 2839, 1646, 1587, 
101 
1409, 1211, 1188, 816, 795, 657, 563 cm-1.  HRMS (ESI+) Calculated for C15H14Cl2IO3+ [M - 
OTs]+: 438.9359; Observed 438.9342.  Mp 193-196 ˚C. 
Compound 24 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 85% yield (2.750 g) as a white powder. 1H NMR (400 
MHz, DMSO-d6) δ 8.58 (s, 1H), 7.95 (s, 2H), 7.49 (d, J = 7.6 Hz, 2H), 
7.10 (d, J = 7.6 Hz, 2H), 6.47 (s, 2H), 3.95 (s, 6H), 3.86 (s, 3H), 2.27 
(s, 3H).  13C NMR (101 MHz,  MSO) δ 166.4, 159.5, 145.2, 140.4, 
138.0, 135.9 – 135.5 (m), 131.1, 130.6 – 130.3 (m), 129.1 (q, JC - F = 
33.1 Hz), 128.2, 125.5, 122.7 (q, JC - F = 273.1 Hz), 120.1, 92.2, 87.6, 57.1, 56.2, 20.8.  19F 
NMR (376 MHz, DMSO-d6) δ -61.4.  FT-IR: 3032, 2942, 2847, 1643, 1590, 1457, 1407, 1212, 
1072, 1037 cm-1.  HRMS (ESI+) Calculated for C16H14ClF3IO3+ [M - OTs]+: 472.9623; Observed 
472.9594.  Mp 168-170 ˚C. 
Compound 25 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 89% yield (2.532 g) as a white powder.  1H NMR (400 MHz, 
DMSO-d6) δ 7.55 (s, 2H), 7.47 (d, J = 8.0 Hz, 2H), 7.21 (s, 1H), 7.10 (d, J 
= 7.9 Hz, 2H), 6.46 (s, 2H), 3.95 (s, 6H), 3.86 (s, 3H), 2.32 – 2.22 (m, 9H). 
13C NMR (101 MHz, DMSO-d6) δ 166.0, 159.3, 145.6, 141.0, 137.5, 
132.9, 131.6, 128.0, 125.4, 115.6, 92.0, 86.7, 57.2, 56.1, 20.7, 20.5.  FT-
IR: 3086, 3054, 3010, 2976, 2945, 2916, 2840, 1582, 1413, 1207, 1189, 1034, 815 cm-1. 
HRMS (ESI+) Calculated for C17H20IO3+ [M - OTs]+: 399.0452; Observed 399.0434. Mp 166-
168 ˚C. 
Compound 27 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 90% yield (3.164 g) as a white powder.  1H NMR 
(400 MHz, DMSO-d6) δ 7.95 – 7.79 (m, 6H), 7.49 (d, J = 8.0 
Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 7.10 (d, J = 7.9 Hz, 2H), 6.44 
(s, 2H), 4.81 (s, 2H), 3.94 (s, 6H), 3.85 (s, 3H), 2.27 (s, 3H).  
13C NMR (101 MHz, DMSO-d6) δ 167.6, 166.1, 159.3, 145.5, 
140.3, 137.6, 134.5, 131.4, 130.2, 129.1, 128.0, 125.4, 123.2, 114.6, 91.9, 87.1, 57.2, 56.0, 
40.2, 20.7.   FT-IR: 3021, 2968, 2842, 1700, 1643, 1392, 1229, 1184, 788, 729 cm-1. HRMS 
(ESI+): Calculated for C24H21INO5+ [M - OTs]+: 530.0459; Observed 530.0438.  Mp 





Compound precursor for 27 – Prepared according to the literature procedure50 on 10 
mmol scale and obtained in 51% yield (2.349 g) as a white 
powder.  1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 2.2 Hz, 1H), 
7.52 (dd, J = 17.0, 2.3 Hz, 1H), 7.31 (d, J = 8.4 Hz, 1H), 7.02 (d 
(appears as a triplet), J = 1.8 Hz, 1H), 6.90 (d, J = 1.8 Hz, 2H), 
5.01 (s, 2H).  13C NMR (101 MHz, CDCl3) δ 159.1, 138.5, 137.5, 
137.3, 135.5, 134.2, 121.9, 121.9, 113.9, 92.7, 69.0.  FTIR: 
3053, 1573, 1265 cm-1.  HRMS (AP+) Calculated for [C13H8BrCl2IO]+: 455.8180; Observed: 
455.8203; Rf: 0.20 in 100% hexane. 
Compound 28 – Prepared according to the general procedure above on 20 mmol scale 
and obtained in 90% yield (11.258 g) as a white powder. 1H NMR (400 
MHz,  MSO) δ 8.36 (dd, J = 6.6, 1.8 Hz, 1H), 8.27 – 8.18 (m, 1H), 7.66 
– 7.56 (m, 1H), 7.47 (d, J = 8.1 Hz, 2H), 7.11 (d, J = 7.9 Hz, 2H), 6.50 (s, 
2H), 3.96 (s, 6H), 3.89 (s, 3H), 2.29 (s, 3H).  13C NMR (101 MHz, DMSO-
d6) δ 166.4, 160.3 (d, JC - F = 259.6 Hz), 159.3, 145.4, 141.5 (d, JC - F = 9.9 
Hz), 137.7, 133.3 (d, JC - F = 4.6 Hz), 128.0, 125.4, 121.3(5) (q, JC - F = 
540.4, 267.6 Hz), 120.7 (d, JC - F = 21.8 Hz), 118.8 (dq, JC - F = 33.3, 13.3 Hz), 110.5 (d, JC - F = 
3.7 Hz), 92.1, 87.5, 57.3, 56.2, 20.7.  19F NMR (376 MHz, DMSO-d6) δ -60.4 (d, J = 12.5 Hz), 
-110.5 (q, J = 12.5 Hz).  FT-IR: 3091, 3063, 3034, 2947, 2886, 2886, 2846, 1469, 1345, 1229, 
1210, 1033, 816, 682, 665, 566 cm-1.  HRMS (ESI+) Calculated for C16H14F4IO3+ [M - OTs]+: 
456.9918; Observed 456.9895.  Mp 133-136 ˚C. 
Compound 29 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 93% yield (2.586 g) as a white powder.  1H 
NMR (400 MHz, MSO) δ 7.86 (d, J = 8.4 Hz, 2H), 7.49 
(d, J = 8.1 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 7.28 (t, J = 
9.1 Hz, 1H), 7.15 – 7.06 (m, 3H), 6.93 – 6.85 (m, 1H), 
6.46 (s, 2H), 4.18 (t, J = 6.5 Hz, 2H), 3.95 (s, 6H), 3.86 
(s, 3H), 3.04 (t, J = 6.4 Hz, 2H), 2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.0, 159.3, 
154.8 (d, J = 2.1 Hz), 151.7 (d, J = 238.8 Hz), 145.6, 142.4, 137.5, 134.3, 132.1, 128.0, 125.4, 
119.6 (d, J = 19.0 Hz), 117.1 (d, J = 22.3 Hz), 115.8, 114.9 (d, J = 6.9 Hz), 113.5, 92.0, 87.0, 
68.3, 57.2, 56.1, 34.19, 20.7.  19F NMR (376 MHz,  MSO) δ -127.1.  FT-IR: 3092, 3059, 
2960, 2927, 2867, 1657, 1394, 1214, 1187, 816 cm-1.  HRMS (ESI+) Calculated for 
C23H22ClFIO4+ [M - OTs]+: 543.0230; Observed 543.0206.  Mp 128 - 130 ˚C.   
Compound precursor for 29 – Prepared according to the literature procedure50 on 10 
mmol scale and obtained in 77% yield (2.915 g) as a 
colorless liquid.  1H NMR (400 MHz, CDCl3) δ 7.64 – 7.56 
(m, 2H), 7.04 – 7.02 (m, 3H), 6.91-6.89 (m, 1H), 6.74-6.70 
(m, 1H), 4.09 (t, J = 6.7 Hz, 2H), 3.02 (t, J = 6.7 Hz, 2H).  13C 
NMR (101 MHz, CDCl3) δ 154.9 (d, JC - F = 2.4 Hz), 152.7 (d, JC - F = 241.3 Hz), 137.6, 137.5, 
131.0, 121.0 (d, JC - F = 19.1 Hz), 116.7 (d, JC - F = 22.5 Hz), 116.2, 114.0 (d, JC - F = 6.7 Hz), 
91.9, 69.0, 35.1.  19F NMR (376 MHz, CDCl3) δ -126.1.  FTIR: 3024, 2253, 1499, 1202, 909 
103 
cm-1.  HRMS (EI) Calculated for C14H11ClFIO: 375.9527; Observed: 375.9516.  Rf: 0.26 in 
100% hexane. 
Compound 30 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 92% yield (2.871 g) as a white powder.  1H 
NMR (400 MHz,  MSO) δ 7.98 (d, J = 2.1 Hz, 1H), 7.86 – 
7.74 (m, 2H), 7.48 (d, J = 8.0 Hz, 2H), 7.20 (t, J = 1.7 Hz, 
1H), 7.14 – 7.06 (m, 4H), 6.45 (s, 2H), 5.19 (s, 2H), 3.92 
(s, 6H), 3.88 (s, 3H), 2.28 (s, 3H).  13C NMR (101 MHz, 
DMSO-d6) δ 166.2, 159.2, 159.1, 145.5, 138.4, 137.6, 
135.5, 135.4, 134.6, 134.4, 128.0, 126.1, 125.4, 121.0, 114.7, 114.0, 91.9, 87.1, 69.0, 57.2, 
56.1, 20.7.  FT-IR: 3033, 2945, 2845, 1640, 1580, 1413, 1212, 1186, 815, 680 cm-1.  HRMS 
(ESI+) Calculated for C22H19BrCl2IO4+ [M - OTs]+: 622.8883; Observed 622.8856.  Mp 
decomposed 180 ˚C.  
Compound 31 – Prepared according to the general procedure above on 10 mmol scale 
and obtained in 95% yield (5.715 g) as a pale yellow powder.  1H NMR 
(400 MHz,  MSO) δ 8.58 (dd, J = 9.1, 4.7 Hz, 1H), 7.83 – 7.71 (m, 1H), 
7.47 (d, J = 8.0 Hz, 2H), 7.15 – 7.06 (m, 3H), 6.62 (s, 2H), 3.97 (s, 3H), 
3.93 (s, 6H), 2.29 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 167.8, 165.7 
(d, JC - F = 262.8 Hz), 160.3, 145.4, 143.0 (d, JC - F = 2.9 Hz), 137.7, 130.2 
(d, JC - F = 10.2 Hz), 128.0, 125.4, 119.5 (d, JC - F = 23.6 Hz), 118.9 (d, JC - F 
= 27.7 Hz), 110.8 (d, JC - F = 7.8 Hz), 92.5, 84.6, 57.5, 56.4, 20.7.  19F NMR (376 MHz, DMSO-
d6) δ -98.1.  FT-IR: 3090, 2949, 2847, 2847, 1643, 1582, 1525, 1460, 1347, 1347, 1212, 
1187, 1034, 869 cm-1.  HRMS (ESI+) Calculated for C15H14FINO5+ [M - OTs]+: 433.9895; 
Observed 433.9876.  Mp 173-174 ˚C. 
Compound 32 – Prepared according to the general procedure above on 10 mmol scale 
and obtained in 95% yield (5.715 g) as a white powder.  1H NMR (400 
MHz,  MSO) δ 8.50 (d, J = 1.8 Hz, 1H), 8.06 (dd, J = 8.2, 1.9 Hz, 1H), 
7.60 – 7.53 (m, 1H), 7.49 – 7.41 (m, 2H), 7.10 (d, J = 7.8 Hz, 2H), 6.48 
(s, 2H), 3.96 (s, 6H), 3.88 (s, 3H), 2.51 (s, 3), 2.28 (s, 3H).  13C NMR (101 
MHz, DMSO-d6) δ 166.3, 159.3, 149.3, 145.5, 138.1, 137.6, 136.5, 
135.4, 129.7, 128.0, 125.4, 112.5, 92.1, 87.3, 57.3, 56.1, 20.7, 19.3.  FT-
IR: 3079, 2975, 2942, 2841, 1581, 1455, 1411, 1272, 1161, 1024 cm1. HRMS (ESI+) 
Calculated for C16H17INO5+ [M - OTs]+: 430.0146; Observed 430.0116.  Mp decomposed 
113 C̊. 
Compound 33 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 90% yield (2.656 g) as a pale yellow powder.  1H NMR 
(400 MHz, DMSO-d6) δ 8.27 – 8.11 (m, 4H), 7.50 – 7.43 (m, 2H), 7.14 
– 7.05 (m, 2H), 6.50 (s, 2H), 3.95 (s, 6H), 3.88 (s, 3H), 2.28 (s, 3H).  
13C NMR (101 MHz, DMSO-d6) δ 166.4, 159.4, 149.0, 145.5, 137.6, 
135.4, 128.0, 125.9, 125.4, 122.3, 92.1, 87.1, 57.3, 56.2, 20.7.  FT-
104 
IR: 3094, 3058, 3017, 2981, 2946, 2846, 1643, 1583, 1527, 1468, 1346, 1346, 1210, 1034, 
848, 816 cm-1. HRMS (ESI+): Calculated for C15H15INO3+ [M - OTs]+: 415.9989; Observed 
415.9963.  Mp 158-165 ˚C. 
Compound 34 – Prepared according to the general procedure above on 1 mmol scale and 
obtained in 85% yield (0.4933 g) as a white powder.  1H NMR (400 
MHz, DMSO-d6) δ 8.86 (d, J = 2.2 Hz, 1H), 8.38 (dd, J = 8.5, 2.3 Hz, 
1H), 7.62 (d, J = 8.5 Hz, 1H), 7.47 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 7.9 
Hz, 2H), 6.47 (s, 2H), 3.96 (s, 6H), 3.88 (s, 3H), 2.29 (s, 3H).  13C NMR 
(101 MHz, DMSO-d6) δ 166.3, 159.2, 153.5, 152.6, 145.3, 145.1, 
137.7, 128.0, 127.4, 125.4, 113.8, 92.0, 87.2, 57.3, 56.1, 20.7.  FT-IR: 3035, 2943, 2847, 
1581, 1455, 1413, 1301, 1210, 1186, 1031, 815 cm-1. HRMS (ESI+) Calculated for 
C14H14ClINO3+ [M - OTs]+: 405.9701; Observed 405.9684. Mp decomposed 165 ˚C 
Compound 35 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 92% yield (2.931g) as a white powder.   1H NMR 
(400 MHz, DMSO-d6) δ 8.06 – 7.78 (m, 8H), 7.47 (d, J = 8.1 
Hz, 2H), 7.10 (d, J = 7.8 Hz, 2H), 6.49 (s, 2H), 3.97 (s, 6H), 3.88 
(s, 3H), 2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 167.6, 
166.1, 159.2, 145.6, 140.3, 137.5, 134.5(3), 134.5(0), 134.2, 
131.4, 130.1, 127.9, 125.4, 123.2, 114.4, 91.9, 87.0, 57.2, 
56.0, 20.7.  FT-IR: 3089, 3056, 2980, 2946, 2839, 2227, 1645, 1582, 1413, 1164, 815.  
HRMS (ESI+): Calculated for C22H19INO3+ [M - OTs]+: 472.0404; Observed 472.0375.  Mp 
174-179 ˚C. 
Compound 36 – Prepared according to the general procedure above on 1 mmol scale and 
obtained in 67% yield (0.397g) as a white powder.  1H NMR (400 MHz, 
 MSO) δ 7.98 – 7.96 (m, 1H), 7.76 – 7.72 (m, 1H), 7.50 – 7.39 (m, 3H), 
7.10 (d, J = 7.8 Hz, 2H), 6.47 (s, 2H), 3.95 (s, 6H), 3.87 (s, 3H), 2.33 (s, 
3H), 2.28 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.2, 159.3, 145.5, 
139.7, 137.6, 134.8, 133.7, 133.6, 132.8, 128.0, 125.4, 112.8, 92.0, 
87.2, 57.3, 56.1, 20.7, 19.4.  FT-IR: 3093, 2945, 2845, 1649, 1582, 1467, 
1414, 1186, 1211, 1033 cm1.  HRMS (ESI+) Calculated for C16H17ClIO3+ [M - OTs]+: 418.9905; 
Observed 418.9877.  Mp 176-178 ˚C. 
Compound 37 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 86%yield (2.395 g) a white powder.  1H NMR (400 MHz, 
DMSO-d6) δ 7.88 – 7.82 (m, 1H), 7.72 (d, J = 7.9 Hz, 1H), 7.55 – 7.40 (m, 
4H), 7.11 (d, J = 7.9 Hz, 2H), 6.48 (s, 2H), 3.95 (s, 6H), 3.88 (s, 3H), 2.28 (s, 
3H). 13C NMR (101 MHz, DMSO-d6) δ 166.3, 161.7 (d, JC - F = 251.9 Hz), 
159.4, 145.5, 137.7, 133.2 (d, JC - F = 7.8 Hz), 130.3 (d, JC - F = 3.2 Hz), 128.0, 
125.4 121.2 (d, JC - F = 24.6 Hz), 118.7 (d, JC - F = 20.8 Hz), 115.6 (d, JC - F = 
7.4 Hz), 92.0, 87.2, 57.3, 56.1, 20.7.  19F NMR (376 MHz, DMSO-d6) δ -108.1.  FT-IR: 3086, 
105 
2945, 2845, 1650, 1581, 1468, 1414, 1344, 1209, 1035 cm-1.  HRMS (ESI+) Calculated for 
C15H15FIO3+ [M - OTs]+: 389.0044; Observed 389.0021.  Mp 181-182 ˚C. 
Compound 38 – Prepared according to the general procedure above on 5 mmol scale with 
the following deviations: i) Stage 1 was run at ambient 
temperature, ii) stage 2 was run at ambient temperature, iii) Stage 
2 reaction progress was assessed by TLC and Stage 2 reaction time 
was thirtyfive minutes.  The product was obtained in 86% yield 
(2.504 g) as a white powder.  1H NMR (400 MHz, DMSO-d6) δ 7.82 (d, J = 8.3 Hz, 2H), 7.49 
(d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.3 Hz, 2H), 7.11 (d, J = 7.9 Hz, 2H), 6.45 (s, 2H), 4.68 (s, 1H), 
3.94 (s, 6H), 3.85 (s, 3H), 3.58 (t, J = 6.6 Hz, 2H), 2.72 (t, J = 6.6 Hz, 2H), 2.27 (s, 3H).13C 
NMR (101 MHz, DMSO-d6) δ 166.0, 159.3, 145.4, 143.9, 137.7, 134.1, 132.0, 128.0, 125.4, 
112.9, 91.9, 87.1, 61.4, 57.2, 56.1, 38.8, 20.7.  FT-IR: 3424, 3083, 3030, 2948, 2906, 1640, 
1577, 1339, 1218, 1177, 1033, 562 cm-1. HRMS (ESI+): Calculated for C17H20IO4+ [M - OTs]+: 
415.0401; Observed 415.0382.  Mp 181-184 ˚C 
Compound 39 – Prepared according to the general procedure above on 5 mmol scale and 
obtained in 77% yield (2.251g) as a white powder.  1H NMR (400 
MHz, DMSO-d6) δ 7.83 (d, J = 8.4 Hz, 2H), 7.47 (d, J = 8.1 Hz, 2H), 
7.34 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 7.8 Hz, 2H), 6.46 (s, 2H), 3.95 (s, 
6H), 3.86 (s, 3H), 2.90 (septet, J = 6.8 Hz, 1H), 2.28 (s, 3H), 1.16 (d, J 
= 6.9 Hz, 6H).  13C NMR (101 MHz, DMSO-d6): δ 166.0, 159.3, 152.3, 
145.7, 137.5, 134.4, 129.6, 127.9, 125.4, 112.6, 91.9, 87.0, 57.2, 56.1, 33.1, 23.4, 20.7.  FT-
IR: 3090, 3059, 3032, 2961, 2867, 2840, 1651, 1583, 1412, 1213, 1186, 815 cm-1. HRMS 
(ESI+): Calculated for C18H22IO3+ [M - OTs]+: 413.0608; Observed 413.0587.  Mp 149-152 ˚C 
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5.2.3. General procedure for anion exchange of aryl(TMB)iodonium tosylates 
 
Aryl(TMB)iodonium tosylate (~ 1 g, 1 equiv) is added to 50 mL boiling water.  If the 
iodonium salt does not dissolve after boiling for 1-2 minutes, then methanol is added 
portion wise until the material is dissolved or the solution has homogenous appearance.  
While still hot, a salt containing the target anion is added in excess.   The exact amount 
required depends on the exchange salt and the iodonium salt and an excess of 10 or more 
equivalents is recommended.  The resulting solution is allowed to naturally cool to 
ambient temperature, before chilling further in an ice-bath.  The mixture is suction 
filtered and the filter cake washed by slurry filtration with water (3 x 30 mL).  The cake is 
dried under suction for 10 – 20 min and then washed by slurry filtration with ethyl ether 
(3x30mL).  The sample is finally dried under high vacuum to remove residual solvent.  If 
iodonium salt is suspected to remain in the aqueous filtrate then it may be extracted with 




5.2.4. Characterization data for anion exchanged aryl(TMB)iodonium salts 
 
Compound 19-Br – Prepared according to the general anion exchange procedure above 
on 2.5 mmol scale, using potassium bromide (20 equiv., 50 mmol, 
6.00 g) and obtained in 96% yield (1.28 g) as an off-off-white to light 
brown powder. 1H NMR (400 MHz, DMSO-d6) δ 8.00 – 7.95 (m, 2H), 
7.71 (d, J = 8.6 Hz, 2H), 7.68 – 7.63 (m, 2H), 7.53 – 7.37 (m, 3H), 6.45 
(s, 2H), 3.95 (s, 6H), 3.87 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 
165.6, 159.2, 142.6, 138.3, 134.6, 129.3, 129.0, 128.3, 126.8, 116.5, 91.9, 89.9, 57.2, 56.0.  
FT-IR: 3072, 2944,  2836, 1636, 1587, 1467, 1338, 1232, 1158, 1033, 824 cm-1.  HRMS 
(ESI+): Calculated for C21H20IO3+ [M - Br]+: 447.0452; Observed 447.0423.  Mp 193-195 ˚C. 
Compound 19-I – Prepared according to the general anion exchange procedure above on 
1 mmol scale, using potassium iodide (11 equiv., 10.6 mmol, 1.765 
g) and obtained in 95% yield  (0.544 g) as a off-white to light brown 
powder.  1H NMR (400 MHz, DMSO-d6) δ 8.03 – 7.95 (m, 2H), 7.77 – 
7.70 (m, 2H), 7.70 – 7.62 (m, 2H), 7.54 – 7.39 (m, 3H), 6.47 (s, 2H), 
3.97 (s, 6H), 3.88 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 165.8, 
159.2, 142.8, 138.2, 134.8, 129.4, 129.0, 128.4, 126.8, 115.6, 92.0, 88.6, 57.3, 56.1.  FT-IR: 
3055, 3036, 2970, 2833, 1645, 1585, 1468, 1229, 1162, 1030, 808 cm-1.  HRMS (ESI+): 
Calculated for C21H20IO3+ [M - I]+: 447.0452; Observed 447.0422.  Mp 164-165 ˚C. 
Compound 19-CF3COO – Prepared according to the general anion exchange procedure 
above on 1 mmol scale, using sodium trifluoroacetate  (20 equiv., 
20.2 mmol, 2.758 g) and obtained in 86% yield (0.481 g) as a off-
white to light brown powder.  1H NMR (400 MHz, DMSO-d6) δ 7.99 
(d, J = 8.1 Hz, 2H), 7.73 (d, J = 8.1 Hz, 2H), 7.67 (d, J = 7.4 Hz, 2H), 
7.53 – 7.35 (m, 3H), 6.47 (s, 2H), 3.97 (s, 6H), 3.87 (s, 3H).  13C NMR (101 MHz, DMSO-d6) 
δ 166.1, 159.5, 158.1 (q, JC - F = 30.9 Hz), 143.1, 138.2, 134.8, 129.5, 129.1, 128.5, 126.9, 
117.2 (q, JC - F = 300.4 Hz), 114.9, 92.0, 87.4, 57.2, 56.0.  19F NMR (376 MHz, DMSO-d6) δ -
73.4.  FT-IR: 3061, 2946, 2843, 1681, 1583, 1414, 1230, 1160, 1026, 803 cm-1.  HRMS (ESI+): 
Calculated for C21H20IO3+ [M – CF3COO]+: 447.0452; Observed 447.0431.  Mp 175-177 ˚C. 
Compound 19-OTf – Prepared according to the general anion exchange procedure above 
on 2 mmol scale with sodium triflate (20 equiv., 40.6 mmol, 6.99g) 
and obtained in 90% yield (1.094g) as a off-white to light brown 
powder.  1H NMR (400 MHz, DMSO-d6) 8.01 (d, J = 8.4 Hz, 2H), 7.76 
(d, J = 8.5 Hz, 2H), 7.68 (d, J = 7.4 Hz, 2H), 7.59 – 7.38 (m, 3H), 6.50 
(s, 2H), 3.99 (s, 6H), 3.89 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 
166.2, 159.4, 143.2, 138.1, 134.9, 129.6, 129.1, 128.5, 126.9, 120.7 (q, J = 322.3 Hz), 114.5, 
92.0, 87.0, 57.3, 56.1.  19F NMR (376 MHz,  MSO) δ -77.7.  FT-IR: 3090, 3063, 2944, 2883, 
2846, 1578, 1457, 1415, 1259, 1162, 1027, 815 cm-1.  HRMS (ESI+): Calculated for 
C21H20IO3+ [M - OTf]+: 447.0452; Observed 447.0471.  Mp decomposed 93 ˚C. 
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Compound 19-PF6 – Prepared according to the general anion exchange procedure above 
on 1 mmol scale with potassium hexafluorophosphate  (20.8 
equiv., 20.8 mmol, 3.821 g) and obtained in 90% yield (0.556 g) as 
a off-white to light brown powder.  1H NMR (400 MHz, DMSO-d6) δ 
8.04 (d, J = 7.9 Hz, 2H), 7.76 (d, J = 7.9 Hz, 2H), 7.67 (d, J = 7.1 Hz, 
2H), 7.59 – 7.36 (m, 3H), 6.51 (s, 2H), 4.00 (s, 6H), 3.90 (s, 3H).  13C 
NMR (101 MHz, DMSO-d6) δ 166.2, 159.4, 143.2, 138.2, 134.9, 129.6, 129.1, 128.5, 
126.9, 114.5, 92.0, 87.0, 57.3, 56.1.   19F NMR (376 MHz, DMSO-d6) δ -70.1 (d, JF- P = 
711.5 Hz).  FT-IR: 3109, 1636, 2949, 1583, 2848, 3065, 1473, 1415, 1231, 1163, 1065, 
843 cm-1.  HRMS (ESI+): Calculated for C21H20IO3+ [M – PF6]+: 447.0452; Observed 
447.0425.  Mp decomposed 127 ˚C. 
Compound 19-BF4 – Prepared according to the general anion exchange procedure above 
on 1 mmol scale, using sodium tetrafluoroborate (104 equiv, 104 
mmol, 11.438 g) and obtained in 96% yield (0.532 g) as a off-white 
to light brown powder.  1H NMR (400 MHz, DMSO-d6) δ 7.99 (d, J = 
8.3 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.67 (d, J = 7.5 Hz, 2H), 7.53 – 
7.38 (m, 3H), 6.49 (s, 2H), 3.97 (s, 6H), 3.88 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 166.2, 
159.4, 143.2, 138.1, 134.9, 129.6, 129.1, 128.6, 126.9, 114.5, 92.0, 87.0, 57.3, 56.1.  19F 
NMR (376 MHz, DMSO-d6) δ -148.3.  FT-IR: 3088, 3061, 2945, 2845, 1625, 1582, 1472, 
1413, 1230, 1034, 817 cm-1.  HRMS (ESI+): Calculated for C21H20IO3+ [M – BF4]+: 447.0452; 
Observed 447.0427.  Mp 160-162 ˚C. 
Compound 28-PF6 – Prepared according to the general procedure above on 1 mmol scale 
and obtained in 61% yield (0.365 g) as a white powder.  1H NMR (600 
MHz,  MSO) δ 8.39 – 8.35 (m, 1H), 8.26 – 8.18 (m, 1H), 7.68 – 7.54 
(m, 1H), 6.49 (s, 2H), 3.96 (s, 6H), 3.88 (s, 3H).  13C NMR (101 MHz, 
 MSO) δ 166.7, 160.6 (dd, J = 260.1, 1.8 Hz), 159.6, 141.7 (d, JC - F = 9.6 
Hz), 133.6, (d, JC - F = 3.9 Hz), 121.54 (q, J = 273.1 Hz), 120.9 (d, J = 21.8 
Hz), 119.2 (dq, J = 33.2, 13.2 Hz),  110.5 (d, J = 3.7 Hz), 92.2, 87.5, 57.4, 
56.2  19F NMR (376 MHz,  MSO) δ -60.6 (d, J = 12.5 Hz), -70.2 (d, JP - F = 711.3 Hz), -110.3 
(q, J = 12.5 Hz).  FT-IR: 3116, 3064, 2952, 2952, 2848, 1414, 1311, 1163, 845 cm1.  HRMS 
(ESI+) Calculated for C16H14F4IO3+ [M – PF6]+: 456.9889; Observed 456.9895.  Mp 
decomposed 126 ˚C. 
Compound 35-Br – Prepared according to the general anion exchange procedure above 
on 1.9 mmol scale, using  (19 equiv., 36 mmol, 4.5 g) and 
obtained in 91% yield (1.733g) as a white powder.  1H NMR 
(400 MHz, DMSO-d6) δ 8.11 – 7.69 (m, 8H), 6.45 (s, 2H), 
3.96 (s, 6H), 3.87 (s, 3H).  13C NMR (101 MHz, DMSO-d6) δ 
165.6, 159.2, 142.8, 140.4, 134.6, 132.9, 129.6, 127.8, 
118.7, 118.6, 110.9, 91.9, 90.9, 57.2, 56.0.  FT-IR: 3089, 
3056, 2980, 2946, 2839, 2227, 1645, 1582, 1413, 1164, 815 cm-1.  HRMS (ESI+) 
Calculated for C22H19INO3+ [M - Br]+: 472.0404; Observed 472.0375.  Mp 175-176 ˚C.  
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5.2.5. Representative procedure for one-pot preparation of
 aryl(TMB)iodonium bromides 
4-methyl-3-nitro iodobenzene (1.33 g, 5.1 mmol) and acetonitrile (5 mL) are added to a 
250 mL round-bottom flask, equipped with a stir bar.  Toluenesulfonic acid monohydrate 
(0.965 g, 5.1 mmol, 1.0 equiv.) is added in one portion, followed by one portion of pre-
dried m-CPBA (1.09 g, 5.1 mmol, 1.0 equiv.).  After attaching a reflux condenser, the 
reaction is lowered into a heat bath set to 77 °C and stirred vigorously.   After 30 minutes, 
the reflux condenser is removed in order to add 1,3,5-trimethoxybenzene (0.858 g, 5.1 
mmol, 1.0 equiv.) in one portion and stirring is continued at 77 °C for 5 minutes.  The 
reaction is removed from heat and 100 mL of water are added.  The mixture is brought to 
near boiling until dissolved and 6.0 g of KBr are added.  After stirring for 2 minutes the 
solution is removed from heat and allowed to cool naturally, before chilling further by 
briefly swirling in an ice-water bath.  The mixture is suction filtered and the filter cake 
washed by slurry filtration with water (3 x 30 mL).  The cake is dried under suction for 10 
– 20 min and then washed by slurry filtration with ethyl ether (3x30mL).  The sample is 
finally dried under high vacuum to remove trace solvent.  If iodonium salt is suspected to 
remain in the aqueous filtrate then it may be extracted with a suitable solvent such as 
dichloromethane or ethyl acetate. After drying under high vacuum, the diaryliodonium 
salt 23-Br was obtained in 83% yield (2.15 g, 4.2 mmol) as a white powder.  
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5.2.6. Characterization data of aryl(TMB)iodonium bromides  
Compound 32-Br – Prepared according to the representative one-pot preparation of 
iodonium bromides above on 5 mmol scale in 82% yield (2.112g), as a 
pale yellow powder.   1H NMR (400 MHz, DMSO-d6) δ 8.51 (d, J = 1.7 
Hz, 1H), 8.06 (dd, J = 8.2, 1.8 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 6.44 (s, 
2H), 3.95 (s, 6H), 3.87 (s, 3H), 2.51 (d, J = 6.7 Hz, 3H).  13C NMR (101 
MHz, DMSO-d6) δ 165.7, 159.1, 149.1, 138.0, 135.8, 135.0, 129.4, 
116.2, 91.9, 91.8, 57.2, 56.0, 19.3.  FT-IR: 3079, 2975, 2942, 2841, 
1581, 1524, 1455, 1411, 1342, 1272, 1161, 1024, 815 cm-1.  HRMS (ESI+) Calculated for 
C16H17INO5+ [M - Br]+: 430.0146; Observed 430.0125.  Mp 166-167 ˚C. 
 
Compound 32-Br – Prepared according to the representative one-pot procedure for 
preparation of iodonium bromides above on 5 mmol scale in 74% 
yield (2.298 g), as an off-white powder.  Ten equivalents, 7.497 g KBr 
were used for the exchange.  1H NMR (400 MHz, DMSO-d6) δ 8.83 
(d, J = 2.2 Hz, 1H), 8.36 (dd, J = 8.5, 2.4 Hz, 1H), 7.60 (d, J = 8.5 Hz, 
1H), 6.44 (s, 2H), 3.96 (s, 6H), 3.88 (s, 3H).  13C NMR (101 MHz, 
DMSO-d6) δ 165.6, 159.0, 153.2, 151.8, 144.7, 127.0, 117.7, 92.1, 91.9, 57.2, 56.1.  FT-IR: 
3075, 3039, 2971, 2942, 2842, 1582, 1454, 1412, 1342, 1161, 817, 731 cm-1.  HRMS (ESI+) 
Calculated for C14H14ClINO3+ [M - Br]+: 405.9701; Observed 405.9684.  Mp 161-163 ˚C. 
5.2.7. Preparation of compounds in Applications section 
Compound 6 –Prepared according to literature procedure50 on 1 mmol scale and obtained 
in 70% yield after purification (0.215g) as a white powder.  The 
crude product was purified by column chromatography with 
silica gel and gradient elution (hexane, 1% ethyl ether, 2% ethyl 
ether).  Mixed fractions were again chromatographed by the 
same procedure for a combined 70% of 33.  1H NMR (400 MHz, 
CDCl3) δ 7.68 – 7.55 (m, 4H), 7.53 – 7.43 (m, 2H), 7.02 – 6.91 (m, 
2H), 3.98 (t, J = 6.6 Hz, 2H), 1.88 – 1.70 (m, 2H), 1.52 – 1.21 (m, 10H), 0.89 (t, J = 6.9 Hz, 
3H).  13C NMR (101 MHz, CDCl3) δ 159.9, 145.2, 132.6, 131.2, 128.3, 127.0, 119.1, 115.1, 
110.0, 68.2, 31.9, 29.4, 29.2(9), 29.2(8), 26.1, 22.7, 14.2.  The spectral data were 
consistent with that previously reported.51 
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Compound 40 – Prepared according to the literature procedure52 on 0.4 mmol scale and 
obtained in 55% yield (0.070 g) as white powder.  1H NMR (400 
MHz, CDCl3) δ 7.59 (dt, J = 8.9, 2.0 Hz, 4H), 7.46 – 7.39 (m, 2H), 
7.37 – 7.28 (m, 3H), 4.31 – 4.19 (m, 2H), 2.88 – 2.76 (m, 1H), 
2.66 – 2.54 (m, 2H), 2.37 (ddd, J = 10.5, 6.9, 3.1 Hz, 1H), 2.09 – 
1.94 (m, 1H), 1.93 – 1.72 (m, 3H), 1.26 (t, J = 7.1 Hz, 3H).  13C 
NMR (101 MHz, CDCl3) δ 206.6, 171.2, 140.6, 140.4, 135.8, 
128.8, 128.2, 127.4, 127.1, 127.1, 66.2, 61.8, 40.9, 35.4, 27.7, 
22.3, 14.0.  FT-IR: 3054, 2985, 1713, 1265, 1133 cm-1. HRMS 
(ESI+) Calculated for C21H23O3+ [M+H]+: 323.1647; Observed: 323.1619. Mp 130.8-132.3 °C. 
Rf: 0.22 in 15% diethyl ether/hexane.  
Compound 43 – Prepared according to the literature procedure53  on 1.0 mmol scale and 
obtained in 78% (0.235 g) as white powder white powder.  1H 
NMR (400 MHz, CDCl3) δ 8.03 – 7.95 (m, 4H), 7.73 – 7.67 (m, 
2H), 7.60 – 7.36 (m, 8H).  13C NMR (101 MHz, CDCl3) δ 146.2, 
141.8, 140.1, 139.2, 133.2, 129.3, 129.1, 128.6, 128.2, 127.9, 
127.6, 127.3.  FT-IR: 1637, 1265, 1158 cm-1. HRMS (ESI+) 
Calculated for C18H15O2S+ [M+H]+: 295.0793; Observed 
295.0763; Mp 142.8-147 °C. Rf: 0.20 in 20% diethyl ether/hexane. 
Compound 45 – Prepared according to the literature procedure54 on 1.0 mmol scale and 
obtained in 80% (0.213 g) as white powder.  1H NMR (400 
MHz, C Cl3) δ 7.58 – 7.52 (m, 4H), 7.45 – 7.39 (m, 2H), 7.35 
– 7.30 (m, J = 5.9, 4.7, 2.3 Hz, 1H), 7.09 – 6.99 (m, 6H).  13C 
NMR (101 MHz, C Cl3) δ 160.1, 157.7, 157.3, 152.8, 140.5, 
136.2, 128.6 (d, JC - F = 33.3 Hz), 127.0, 126.8, 120.6 (d, JC - F 
= 8.2 Hz), 118.4, 116.3 (d, JC - F = 23.2 Hz).  19F NMR (376 MHz, C Cl3) δ -119.9.  FT-IR: 
1500, 1265, 1214   cm-1. HRMS (EI+) Calculated for C18H13FO: 264.0950; Observed: 





5.2.8. Qualitative Stability Study 
Small samples of powdered iodonium salts were placed into scintillation vials and left 
adjacent to a window, exposed to ambient sunlight.  A second sample of each salt was 
placed into a scintillation vial and wrapped with aluminum foil.   The samples were 
periodically photographed.   Any discoloration or change in consistency, appreciable upon 
visual inspection, was taken as evidence for decomposition.  The photographs below are 
selected in order to illustrate the range of decomposition observed.  See Figure below for 
a summary of results.  Decomposition has not been observed when these compounds are 
stored in a freezer.   
 
Figure 67. Qualitative stability study, light samples were exposed to ambient sunlight, dark samples 
were covered with aluminium foil.  
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5.2.9.  NMR spectra for aryl(TMB)iodonium tosylates 
 
Figure 68. 1H NMR spectrum of 6 at 400 MHz in CDCl3 at 298K 
 
 




Figure 70. 1H NMR spectrum of 11 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 71. 13C NMR spectrum of 11 at 101 MHz in DMSO-d6 at 298K 
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Figure 72. 1H NMR spectrum of 12 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 73. 13C NMR spectrum of 12 at 101 MHz in DMSO-d6 at 298K 
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Figure 74. 1H NMR spectrum of 13 at 400 MHz in DMSO-d6 at 298K 
  
 




Figure 76. 1H NMR spectrum of 14 at 400 MHz in DMSO-d6 at 298K 
 
Figure 77. 13C NMR spectrum of 14 at 101 MHz in DMSO-d6 at 298K 
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Figure 78. 1H NMR spectrum of 15 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 79. 13C NMR spectrum of 15 at 101 MHz in DMSO-d6 at 298K 
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Figure 80. 1H NMR spectrum of 16 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 81. 13C NMR spectrum of 16 at 101 MHz in DMSO-d6 at 298K 
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Figure 82. 1H NMR spectrum of 17 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 83. 13C NMR spectrum of 17 at 101 MHz in DMSO-d6 at 298K 
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Figure 84. 1H NMR spectrum of 18 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 85. 13C NMR spectrum of 18 at 101 MHz in DMSO-d6 at 298K 
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Figure 86. 1H NMR spectrum of 19 at 400 MHz in DMSO-d6 at 298K 
 
 




Figure 88. 1H NMR spectrum of 19-Br at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 89. 13C NMR spectrum of 19-Br at 101 MHz in DMSO-d6 at 298K 
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Figure 90. 1H NMR spectrum of 19-I at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 91. 13C NMR spectrum of 19-I at 101 MHz in DMSO-d6 at 298K 
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Figure 92. 1H NMR spectrum of 19-CF3COO at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 93. 13C NMR spectrum of 19-CF3COO at 101 MHz in DMSO-d6 at 298K 
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Figure 94. 19F NMR spectrum of 19-CF3COO at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 95. 1H NMR spectrum of 19-OTf at 400 MHz in DMSO-d6 at 298K 
127 
 
Figure 96. 13C NMR spectrum of 19-OTf at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 97. 19F NMR spectrum of 19-OTf at 376 MHz in DMSO-d6 at 298K 
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Figure 98. 1H NMR spectrum of 19-PF6 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 99. 13C NMR spectrum of 19-PF6 at 101 MHz in DMSO-d6 at 298K 
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Figure 100. 19F NMR spectrum of 19-PF6 at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 101. 1H NMR spectrum of 19- BF4 at 400 MHz in DMSO-d6 at 298K 
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Figure 102. 13C NMR spectrum of 19-BF4 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 103. 19F NMR spectrum of 19-BF4 at 376 MHz in DMSO-d6 at 298K 
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Figure 104. 1H NMR spectrum of 20 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 105. 13C NMR spectrum of 20 at 101 MHz in DMSO-d6 at 298K 
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Figure 106. 1H NMR spectrum of 21 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 107. 13C NMR spectrum of 21 at 101 MHz in DMSO-d6 at 298K 
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Figure 108. 19F NMR spectrum of 21 at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 109. 1H NMR spectrum of 22 at 400 MHz in DMSO-d6 at 298K 
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Figure 110. 13C NMR spectrum of 22 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 111. 1H NMR spectrum of 24 at 400 MHz in DMSO-d6 at 298K 
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Figure 112. 13C NMR spectrum of 24 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 113. 19F NMR spectrum of 24 at 376 MHz in DMSO-d6 at 298K 
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Figure 114. 1H NMR spectrum of 25 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 115. 13C NMR spectrum of 25 at 101 MHz in DMSO-d6 at 298K 
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Figure 116. 1H NMR spectrum of 26 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 117. 13C NMR spectrum of 26 at 101 MHz in DMSO-d6 at 298K 
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Figure 118. 1H NMR spectrum of 27 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 119. 13C NMR spectrum of 27 at 101 MHz in DMSO-d6 at 298K 
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Figure 120. 1H NMR spectrum of 28 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 121. 13C NMR spectrum of 28 at 101 MHz in DMSO-d6 at 298K 
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Figure 122. 19F NMR spectrum of 28 at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 123. 1H NMR spectrum of 28-PF6 at 600 MHz in DMSO-d6 at 298K 
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Figure 124. 13C NMR spectrum of 28-PF6 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 125. 19F NMR spectrum of 28-PF6 at 376 MHz in DMSO-d6 at 298K 
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Figure 126. 1H NMR spectrum of 29 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 127. 13C NMR spectrum of 29 at 101 MHz in DMSO-d6 at 298K 
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Figure 128. 19F NMR spectrum of 29 at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 129. 1H NMR spectrum of precursor for 29 at 400 MHz in CDCl3 at 298K 
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Figure 130. 13C NMR spectrum of precursor for 29 at 101 MHz in CDCl3 at 298K 
 
 
Figure 131. 19F NMR spectrum of precursor for 29 at 376 MHz in CDCl3 at 298K 
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Figure 132. 1H NMR spectrum of 30 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 133. 13C NMR spectrum of 30 at 101 MHz in DMSO-d6 at 298K 
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Figure 134. 1H NMR spectrum of precursor for 30 at 400 MHz in CDCl3 at 298K 
 
 
Figure 135. 13C NMR spectrum of precursor for 30 at 101 MHz in CDCl3 at 298K 
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Figure 136. 1H NMR spectrum of 31 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 137. 13C NMR spectrum of 31 at 101 MHz in DMSO-d6 at 298K 
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Figure 138. 19F NMR spectrum of 31 at 376 MHz in DMSO-d6 at 298K 
 
 
Figure 139. 1H NMR spectrum of 32 at 400 MHz in DMSO-d6 at 298K 
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Figure 140. 13C NMR spectrum of 32 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 141. 1H NMR spectrum of 32-Br at 400 MHz in DMSO-d6 at 298K 
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Figure 142. 13C NMR spectrum of 32-Br at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 143. 1H NMR spectrum of 33 at 400 MHz in DMSO-d6 at 298K 
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Figure 144. 13C NMR spectrum of 33 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 145. 1H NMR spectrum of 34 at 400 MHz in DMSO-d6 at 298K 
152 
 
Figure 146. 13C NMR spectrum of 34 at 101 MHz in DMSO-d6  at 298K 
 
 
Figure 147. 1H NMR spectrum of 34-Br at 400 MHz in DMSO-d6 at 298K 
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Figure 148. 13C NMR spectrum of 34-Br at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 149. 1H NMR spectrum of 35 at 101 MHz in DMSO-d6 at 298K 
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Figure 150. 13C NMR spectrum of 35 at 101 MHz in DMSO-d6 at 298K 
 
 




Figure 152. 13C NMR spectrum of 35-Br at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 153. 1H NMR spectrum of 36 at 400 MHz in DMSO-d6 at 298K 
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Figure 154. 13C NMR spectrum of 36 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 155. 1H NMR spectrum of 37 at 400 MHz in DMSO-d6 at 298K 
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Figure 156. 13C NMR spectrum of 37 at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 157. 19F NMR spectrum of 37 at 376 MHz in DMSO-d6 at 298K 
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Figure 158. 1H NMR spectrum of 38 at 400 MHz in DMSO-d6 at 298K 
 
 
Figure 159. 13C NMR spectrum of 38 at 101 MHz in DMSO-d6 at 298K 
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Figure 160. 1H NMR spectrum of 39 at 400 MHz in DMSO-d6 at 298K 
 
 




Figure 162. 1H NMR spectrum of 40 at 400 MHz in CDCl3 at 298K 
 
Figure 163. 13C NMR spectrum of 40 at 101 MHz in CDCl3 at 298K 
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Figure 164. 1H NMR spectrum of 43 at 400 MHz in CDCl3 at 298K 
 
 
Figure 165. 13C NMR spectrum of 43 at 101 MHz in CDCl3 at 298K 
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Figure 166. 1H NMR spectrum of 45 at 400 MHz in CDCl3 at 298K 
 
 
Figure 167. 13C NMR spectrum of 45 at 101 MHz in CDCl3 at 298K 
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5.3. Supporting Information for Chapter 3 
5.3.1. Procedure A: Synthesis of aryl(TMP)iodonium tosylates2 
 
Figure 169. Synthesis of aryl(TMP)iodonium tosylates 
 
Aryl iodide (5 mmol, 1 equiv.) and acetonitrile (5 mL) were added to a 50 mL round-
bottom flask, equipped with a magnetic stir bar.  Toluenesulfonic acid (5.05 mmol, 1.01 
equiv.) was added in one portion, followed by one portion of m-CPBA (5.05 mmol, 1.01 
equiv.) at room temperature.  After attaching a reflux condenser, the reaction was 
lowered into an oil bath set to 77 °C and stirred vigorously.   After 30 minutes, the reflux 
condenser was removed in order to add (5.05 mmol, 1.01 equiv.) 1,3,5-
trimethoxybenzene (TMB) in one portion and stirring was continued at 77 °C for 5 
minutes.  The reaction was removed from heat and concentrated under reduced 
pressure.  The crude residue was triturated with diethyl ether.  The precipitate was 
isolated by vacuum filtration and washed by slurry filtration with diethyl ether (3 × 20 
mL).  After drying under high vacuum the diaryliodonium salt was obtained in 




5.3.2. Procedure B: Anion exchange of aryl(TMP)iodonium tosylates2 
 
Figure 170. Anion exchange of aryl(TMP)iodonium tosylates  
 
Aryl(TMP)iodonium tosylate (~ 1 g, 1 equiv) is added to 50 mL boiling water.  If the 
iodonium salt does not dissolve after boiling for 1-2 minutes, then methanol is added in 
small portions until the material is dissolved or the solution has homogenous 
appearance.  While still hot, a salt containing the target anion is added in excess.   The 
exact amount required depends on the exchange salt and the iodonium salt and an 
excess of 10 or more equivalents is recommended.  The resulting solution is allowed to 
naturally cool to ambient temperature, before chilling further in an ice-bath.  The 
precipitate is isolated by suction filtration and the filter cake washed by slurry filtration 
with water (3 x 30 mL).  The cake is dried under suction for 10 – 20 min and then 
washed by slurry filtration with ethyl ether (3 x 30 mL).  The sample is finally dried under 
high vacuum to remove residual solvent.  If product is suspected in the aqueous wash 





5.3.3. Procedure C: Aryl(TMP)iodonium bromides to acetate exchange  
 
Figure 171. Aryl(TMP)iodonium bromides to acetate exchange  
 
Aryl(TMP)iodonium bromide, (2 mmol) is added to an Erlenmeyer flask with a Teflon 
coated magnetic stirbar and dissolved in 50 mL of hot acetonitrile.  Silver acetate (2 g, 
12 mmol) is added to the stirred solution and a yellow precipitate immediately forms.  
The flask is removed from heat, allowed to cool naturally and the precipitate gradually 
turns grey.  When cool, the solution is repeatedly filtered through a fine fritted funnel 
containing packed Celite® until grey color is not observed.  The solvent is evaporated 





5.3.4. Determination of GC response factors for 2a and 2b 
 
 
Table 13.  Determination of GC response factors for 2a and 2b.  
 
Figure 172. Determination of GC response factors for 2a  
 










mes-Br 0.0099 0.0000 0.0100 0.002 0.000
tBuPhN3 0.0101 0.0020 0.0080 0.441 0.246
0.0040 0.0060 1.108 0.656
0.0060 0.0040 2.171 1.476





mes-Br 0.0080 0.001 0.009 0.22 0.11
COOMePhN3 0.0072 0.002 0.008 0.42 0.25
0.003 0.007 0.76 0.43
0.004 0.006 1.15 0.67
0.005 0.005 1.74 1.00
Response factor 1a = 1.51 
Response factor 20 = 1.77 
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5.3.5. Procedure D: Aryl azidation with pre-exchanged diaryliodonium salts  
 
Figure 174. Aryl azidation with pre-exchanged diaryliodonium salts 
 
Aryl(TMP)iodonium salt (0.1 mmol, 1eq) is added to a vial with a magnetic stirbar.  
Sodium azide (0.2 mmol, 2 equiv.) is added, followed by 1 mL anhydrous diglyme.  The 
solution is stirred at 50 °C for two hours, removed from heat and diluted with 1 mL of 
aqueous bicarbonate solution.  Upon addition of 10 μL of internal standard 
(bromomesitylene), the reaction is extracted with ethyl acetate, filtered through a 
Celite® plug and analyzed by GC/MS.   
 
 
5.3.6. Procedure E: Aryl azidation of aryl(TMP)iodonium tosylates with a dope
 salt. 
 
Figure 175. Aryl azidation of aryl(TMP)iodonium tosylates with a dope salt  
 
Aryl(TMP)iodonium tosylate (0.1 mmol, 1eq) and is added to a vial with a magnetic 
stirbar.  A sodium salt with the desired anion is added (0.4 mmol, 4 equ), followed by 1 
mL of anhydrous diglyme.  The mixture is vigorously stirred at room temperature for 15 
min.  Sodium azide (2 mmol, 2 equiv) is added and the mixture is stirred at 50 °C for two 
hours and then removed from heat and diluted with 1 mL of aqueous  sodium 
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bicarbonate solution.  Upon addition of (10 μL, ~1 eq) of internal standard 
(bromomesytilene), the reaction is extracted with ethyl acetate, filtered through a celite 
plug and analyzed by GC/MS. 
5.3.7. Screening Table: Corrected GC-MS yields (2 equiv. NaN3, 50 ˚C, 2 hours) 
 
Table 14.  Screening Table: Corrected GC-MS yields (2 equiv. NaN3, 50 ˚C, 2 hours).  
5.3.8. Raw (uncorrected) GC-MS data for recapitulation of literature screening 
Each of the three examples below were adapted from the indicated literature 
preparation.  The literature preparations were modified only as follows: i) 
diphenyliodonium tosylate was used in each case, ii) diphenyliodonium tosylate, solvent 
and the sodium salt of the indicated x-group were stirred for fifteen minutes at ambient 
temperature before adding other reactants.  Product formation was confirmed by 






















































1a-diglyme 60 34 0 11 0 54 10 17 59 18 6 6 64
1b-diglyme 64 58 16 61 25 60 59 51 44 63 60 44 53
1a-MeCN 39 35 0 5 3 42 0 0 38 0 0 0 38














5.3.9. Characterization data  
Compound 14-Br –   Prepared from 14 according to Procedure B on 2 mmol scale, using 
potassium bromide (12 g, 10 equiv.) and obtained in 95% yield 
(1.138 g) as a white powder. 1H NMR (600 MHz, DMSO-d6 & 
CD3O ) δ 7.81 (d, J = 7.0 Hz, 2H), 7.43 (d, J = 7.0 Hz, 2H), 6.39 (s, 
2H), 3.92 (s, 6H), 3.83 (s, 3H), 1.24 (s, 9H).  13C NMR (151 MHz, 
DMSO-d6 & CD3O ) δ 165.58 , 159.27 , 153.86 , 133.89 , 128.31 , 
114.65 , 91.92 , 90.28 , 57.20 , 56.06 , 34.70 , 30.73. FTIR: 3051, 
2953, 2868, 2841, 1576, 1458, 1409, 1207, 1121, 814 cm-1. HRMS (ESI+): Calculated for 
C19H24IO3+ [M - Br]+:  427.0765; Observed: 427.0768. Mp 194 ˚C. 
Compound 14-Cl –   Prepared from 14 according to Procedure B on 2 mmol scale, using 
sodium chloride (12.6 g, 100 equiv.) and obtained in 94% (0.873 g) 
yield as a white powder. 1H NMR (600 MHz, DMSO-d6 & CD3O ) δ 
7.81 (d, J = 7.6 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 6.40 (s, 2H), 3.92 (s, 
6H), 3.84 (s, 3H), 1.23 (s, 9H).  13C NMR (151 MHz, DMSO-d6 & 
CD3O ) δ 166.6, 159.9, 155.0, 134.4, 128.7, 113.4, 92.0, 88.0, 57.1, 









PF6 58 311 
TFA 54 303 
OTs 47 229 
BF4 40 245 
OTf 38 218 
Br 0 0 
     
 
OAc 77 55 
PF6 0 0 
Cl 0 0 
OTf 0 2 




Otf 87 38 
BF4 97 98 
Br 90 15 
Ots 19 62 
 
Figure 176. Raw GC/MS data (uncorrected) that is shown in Figure 49 




810, 670 cm-1. HRMS (ESI+): Calculated for C19H24IO3+ [M - Cl]+:  427.0765, Observed: 
427.0759.  Mp 207 ˚C.  
Compound 14-OAc –   Prepared to Procedure C by stirring 14-Br (3.8 g, 7.5 mmol) into 
hot acetonitrile until completely dissolved.  Silver acetate (1.704 g, 
10.3 mmol) was added and a yellow powder immediately 
precipitated and gradually turned grey. The product was obtained 
as a white powder in 70% yield.  1H NMR (400 MHz, CD3O ) δ 7.90 
(d, J = 8.6 Hz, 2H), 7.52 (d, J = 8.6 Hz, 2H), 6.43 (s, 2H), 4.01 (s, 6H), 
3.91 (s, 3H), 1.88 (s, 3H), 1.32 (s, 9H). 13C NMR (101 MHz, MeO ) δ 
178.7, 167.2, 160.1, 155.7, 134.3, 128.6, 111.3, 91.5, 85.3, 56.3, 55.3, 34.6, 30.0, 22.9. 
FT-IR: 3101, 3068, 3023, 2960, 2911, 2869, 2845, 1581, 1552, 1382, 1338, 1235, 1117, 
1069, 824, 637 cm-1.  HRMS (ESI+): Calculated for C19H24IO3+ [M - OAc]+:  427.0765, 
Observed: 427.0747.  Mp 149 - 151˚C. 
Compound 14-OTf –   Prepared from 14 according to Procedure B on 2 mmol scale, 
using sodium triflate (5.0 g, 29 equiv.) and obtained in 92% (1.06 g, 
1.8 mmol) yield as a white powder.  1H NMR (400 MHz, DMSO-d6) 
δ 7.84 (d, J = 8.7 Hz, 2H), 7.50 (d, J = 8.7 Hz, 2H), 6.48 (s, 2H), 3.96 
(d, J = 5.8 Hz, 6H), 3.87 (d, J = 4.7 Hz, 3H), 1.25 (s, 9H). 13C NMR 
(101 MHz, DMSO-d6) δ 166.1 , 159.3 , 154.7 , 134.2 , 128.7 , 120.7 
(q, JC - F = 322.5 Hz), 112.5 , 92.0 , 86.9 , 57.3 , 56.1 , 34.8 , 30.7 . 19F NMR (376 MHz, 
DMSO-d6) δ (ppm): −77.7.  FT-IR: 3070, 2955, 2870, 2847, 1580, 1471, 1415, 1243, 1210, 
1125, 1026, 814, 635 cm-1.  HRMS (ESI+): Calculated for C19H24IO3+ [M - OTf]+:  427.0765, 
Observed: 427.0765.  Mp 78 – 79 ˚C. 
Compound 14-BF4 –   Prepared from 14 according to Procedure B on 2 mmol scale, using 
sodium tetrafluoroborate (22 g, 95 equiv.) and obtained in 91% 
yield (0.930 g, 1.81 mmol) as a white powder.  1H NMR (400 MHz, 
DMSO-d6) δ 7.85 (d, J = 8.6 Hz, 2H), 7.50 (d, J = 8.6 Hz, 2H), 6.48 (s, 
2H), 3.97 (s, 6H), 3.88 (s, 3H), 1.25 (s, 9H). 13C NMR (101 MHz, 
DMSO-d6) δ 166.6, 159.9, 155.2, 134.7, 129.2, 113.0, 92.5, 87.4, 
57.8, 56.6, 35.3, 31.2.  19F NMR (376 MHz, DMSO-d6) δ (ppm): 
−148.3.  FT-IR: 3022, 2903, 2870, 1579, 1462, 1347, 1232, 1126, 1050, 995, 808, 665cm-
1.  HRMS (ESI+): Calculated for C19H24IO3+ [M – BF4]+:  427.0765, Observed: 427.0747.  Mp 
162 ˚C. 
Compound 20-Br –   Prepared from 20 according to Procedure B on 2 mmol scale, using 
potassium bromide (12 g, 100 equiv.) and obtained in 85% yield 
(0.930 g, 1.81 mmol) as a white powder. 1H NMR (600 MHz, 
DMSO-d6) δ 8.27 – 7.79 (m, 4H), 6.49 (s, 2H), 3.97 (s, 6H), 3.89 – 
3.52 (m, 6H). 13C NMR (151 MHz, DMSO-d6) δ 166.9, 165.6, 
159.9, 135.1, 132.7, 132.3, 121.4, 92.6, 87.3, 57.8, 56.6, 53.1. 
FT-IR: 3086, 2988, 2972, 2901, 1721, 1579, 1279, 1121 cm-1.  
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HRMS (ESI+): Calculated for C17H18IO5+ [M - Br]+: 429.0193; Observed 429.0167.  Mp 152 
˚C.   
Compound 20-Cl –   Prepared from 20 according to Procedure B on 3.25 mmol scale, 
using sodium chloride (14 g, 74 equiv.) and obtained in 94 % 
yield (1.42 g) as a white powder.  1H NMR (400 MHz, DMSO-d6 
and CD3O ) δ 8.03 – 7.83 (m, 4H), 6.37 (s, 2H), 3.90 (s, 6H), 3.82 
(s, 3H), 3.82 (s, 3H).  13C NMR (101 MHz, DMSO-d6 & CD3O ) δ 
166.4, 165.0, 159.4, 134.0, 132.1, 131.2, 121.1, 91.4, 87.3, 56.4, 
55.3, 51.7. FT-IR: 3071, 2988, 2971, 2944, 2901, 1733, 1577, 
1280, 1116, 748 cm-1.  HRMS (ESI+): Calculated for C17H18IO5+ [M - Cl]+: 429.0193; 
Observed 429.0170.  Mp 167 ˚C.   
Compound 20-TFA –   Prepared from 20 according to Procedure B on 2 mmol scale, 
using sodium trifluoroacetate (14 g, 50 equiv.) and obtained in 
33 % yield (1.42 g) as a white powder.  The filtrate in the final 
wash step was not extracted. 1H NMR (400 MHz, DMSO-d6) δ 
8.06 (d, J = 7.8 Hz, 2H), 7.96 (d, J = 7.9 Hz, 2H), 6.48 (s, 2H), 3.95 
(s, 6H), 3.88 (s, 3H), 3.84 (s, 3H). 13C NMR (151 MHz, DMSO-d6) 
δ 166.7, 165.7, 160.0, 15j8.6 (q, JC-F = 31.1 Hz), 134.9, 132.4, 
132.1, 117.7 (q, JC-F = 300.1 Hz), 92.5, 88.1, 57.7, 56.6, 53.0. 19F 
NMR (376 MHz, DMSO-d6) δ -73.4 (ppm):  FT-IR: 3092, 3070, 
2988, 2972, 2956, 2901, 1723, 1662, 1581, 1273, 1108, 763 cm-1.  HRMS (ESI+): 
Calculated for C17H18IO5+ [M – CF3COO]+: 429.0193; Observed 429.0200.  Mp 168 ˚C.   
Compound 20-OAc –   Prepared to Procedure C by stirring 20-Br (2.314 g, 4.55 mmol) 
into hot acetonitrile until completely dissolved.  Silver acetate 
(2.3 g, 3 equiv) was added and a yellow powder immediately 
precipitated and gradually turned grey. The product was 
obtained as a white powder in 47% yield (1.033 g, 2.12 mmol). 
1H NMR (400 MHz, CD3O ) δ 8.12 – 8.00 (m, 4H), 6.45 (s, 2H), 
4.00 (s, 6H), 3.95 – 3.91 (m, 6H), 1.89 (s, 3H). 13C NMR (101 
MHz, CD3O ) δ 178.4, 167.5, 165.4, 160.1, 134.3, 133.1, 131.8, 119.5, 91.6, 85.1, 56.4, 
55.3, 51.8, 22.6. FTIR: 3079, 3053, 3028, 2947, 2907, 2834, 1716, 1579, 1549, 1388, 
1339, 1277, 1225, 1158, 1116, 1066, 807, 761, 643 cm-1. HRMS (ESI+): Calculated for 
C17H18IO5+ [M – OAc]+: 429.0193; Observed 429.0191.  Mp 111 ˚C. 
Compound 20-OTf –   Prepared from 20 according to Procedure B on 1 mmol scale, 
using sodium triflate (3 g, 17.5 equiv) and obtained in 84 % 
yield as a white powder. 1H NMR (400 MHz, DMSO-d6) δ 8.05 
(d, J = 8.6 Hz, 2H), 7.98 (d, J = 8.6 Hz, 2H), 6.49 (s, 2H), 3.95 (s, 
6H), 3.88 (s, 3H), 3.86 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ 
166.4 , 165.1 , 159.4 , 134.6 , 132.2 , 131.8 , 120.8, 120.7 (q, JC-F 
= 322.4 Hz), 92.1 , 86.8 , 57.3 , 56.2 , 52.6.  19F NMR (376 MHz, 
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DMSO-d6) δ -77.7 (s).  FTIR: 3107, 2950, 2849, 1732, 1576, 1464, 1352, 1275, 1229, 
1159, 1029, 816, 665 cm-1. HRMS (ESI+): Calculated for C17H18IO5+ [M – OTf]+: 429.0193; 
Observed 429.0191.  Mp 104 ˚C.   
Compound 20-BF4 –   Prepared from 20 according to Procedure B on 2 mmol scale, using 
sodium tetrafluoroborate (11 g, 50 equiv) and obtained in 77 % 
yield (0.8079 g) as a white powder. The filtrate was not 
extracted to recover more product. . 1H NMR (400 MHz, DMSO-
d6 and CD3O ) δ 8.61 – 7.78 (m, 4H), 6.49 (s, 2H), 4.01 (s, 6H), 
3.92 – 3.78 (m, 6H).  13C NMR (101 MHz, DMSO-d6 and CD3O ) δ 
166.9, 165.6, 159.9, 135.1, 132.7, 132.3, 121.4, 92.6, 87.3, 57.8, 
56.6, 53.1.  19F NMR (376 MHz, DMSO-d6 and CD3O ) δ -148.30 (s). FT-IR: 3089, 2988, 
2971, 2901, 1716, 1578, 1549, 1277, 1159, 1115, 1066, 642 cm-1. HRMS (ESI+): 
Calculated for C17H18IO5+ [M – BF4]+: 429.0193; Observed 429.0186. Mp 168 ˚C 
(decomposed).   
Compound 50 – Prepared according to Procedure D on 0.5 mmol scale and obtained in 
94% (0.0818 g, 0.47 mmol) yield as a pale yellow oil. The crude product 
was adsorbed onto silica and purified by column chromatography using 
hexanes as the eluent. The characterization data agree with previously 
reported values.55 1H NMR (400 MHz, CDCl3) δ 7.31 (d, J = 8.6 Hz, 2H), 
6.90 (d, J = 8.6 Hz, 2H), 1.27 (s, 9H).  13C NMR (101 MHz, CDCl3) δ 147.9, 
137.2, 126.6, 119.0, 34.5, 31.3.  
Compound 51 – Prepared according to Procedure D on 0.1 mmol scale with the 
following deviations: i) the crude reaction was extracted with pentane 
and purified by column chromatography on silica using 5% ethyl ether 
followed by 10% ethyl ether in pentane.  The product was obtained in 
95% (0.0167 g, 0.095 mmol) yield as a pale yellow solid. The 
characterization data agree with previously reported values.56 1H NMR 
(600 MHz, CDCl3) δ 8.03 (d, J = 8.1 Hz, 1H), 7.07 (d, J = 8.1 Hz, 1H), 3.91 (s, 1H).   13C NMR 
(151 MHz, CDCl3) δ 166.3, 144.8, 131.4, 126.7, 118.8, 52.2.  
 
Compound 56 – Prepared according to Procedure D on 0.1 mmol scale with the 
following deviations: i) acetonitrile was used as the solvent, ii) the 
crude reaction was extracted with ethyl ether and purified by 
column chromatography on silica using ethyl ether in hexanes 
(1:1) to followed by neat ethyl ether.  The product was obtained in 
86% (0.014 g, 0.086 mmol) yield as a colorless oil. The characterization data agree with 
previously reported values.57 1H NMR (600 MHz, CDCl3) δ 7.21 (d, J = 7.6 Hz, 2H), 6.98 (d, 
J = 7.4 Hz, 2H), 3.84 (t, J = 6.4 Hz, 2H), 2.84 (t, J = 6.4 Hz, 2H), 1.70 (s, 1H).  13C NMR (101 
MHz, CDCl3) δ 138.3, 135.5, 130.5, 119.2, 65.9, 38.6.  
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Compound 57 – Prepared according to Procedure D on 0.5 mmol scale and obtained in 
93% (0.0828 g, 0.465 mmol) yield as a yellow solid.  1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, J = 2.4 Hz, 1H), 7.33 (d, J = 8.3 Hz, 1H), 7.17 (dd, J = 
8.3, 2.4 Hz, 1H), 2.57 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 149.7, 139.3, 
134.1, 130.0, 123.4, 115.2, 20.0.  FT-IR: 3081, 2988, 2938, 2901, 2110, 
1527, 1303, 1338, 1066, 907, 872, 729 cm-1. HRMS (ESI+) Calculated for C7H6N4O2+ [M - 
H]+: 178.0491; Observed 178.0507. Mp 67 - 68 ˚C 
Compound 58 – Prepared according to Procedure   on 0.5 mmol scale and obtained in 
92% (0.172 g, 0.462 mmol) yield.  1H NMR (400 MHz, CDCl3) 
δ 7.55 (d, J = 8.5 Hz, 1H), 7.17 (d, J = 2.7 Hz, 1H), 7.01 (t, J = 
1.8 Hz, 1H), 6.91 – 6.85 (m, 3H), 5.04 (s, 2H).  13C NMR (101 
MHz, CDCl3) δ 159.1, 140.0, 137.0, 135.6, 133.9, 121.9, 
120.0, 119.2, 117.2, 114.0, 69.4. FT-IR: 3095, 3055, 2920, 
2842, 2115, 2075, 1590, 1572, 1299, 1057, 804, 662 cm-1. 
HRMS (ESI+) Calculated for C13H8BrCl2N3O  [M - H]+: 370.9228; Observed 370.9250. Mp 
98 - 99˚C 
Compound 59 – Prepared according Procedure D on 0.1 mmol scale with the following 
deviations: i) acetonitrile was used as the solvent.  The crude product 
was purified by column chromatography on silica using 10% ethyl 
ether in hexanes.  The product was obtained in 74% (0.0114 g, 0.074 
mmol) yield as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.14 (dd, J = 
2.1, 1.5 Hz, 1H), 7.45 – 7.25 (m, 2H).  13C NMR (101 MHz, CDCl3) δ 147.1, 140.7, 136.4, 
128.9, 125.0. FT-IR: 3086, 3055, 2131, 2099, 1455, 1299, 824, 565 cm-1. HRMS (ESI+) 
Calculated for C5H3ClN4 [M - H]+: 154.0046 Observed 154.0066. Mp 39 ˚C.  
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5.3.10. NMR spectra for aryl(TMP)iodonium tosylates  
 
Figure 177. 1H NMR spectrum of 14-Br at 600 MHz in DMSO-d6 and CD3OD at 298K 
 
 




Figure 179. 1H NMR spectrum of 14-Cl at 400 MHz in DMSO-d6 and CD3OD at 298K 
 
 




Figure 181. 1H NMR spectrum of 14-OAc at 400 MHz in CD3OD at 298K 
 
 
Figure 182. 13C NMR spectrum of 14-OAc at 101 MHz in CD3OD at 298K 
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Figure 183. 1H NMR spectrum of 14-OTf at 400 MHz in DMSO-d6  at 298K 
 
 




Figure 185. 19F NMR spectrum of 14-OTf at 376 MHz in DMSO-d6  at 298K 
 
 
Figure 186. 1H NMR spectrum of 14-BF4 at 400 MHz in DMSO-d6  at 298K 
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Figure 187. 1H NMR spectrum of 20-Br at 600 MHz in DMSO-d6 at 298K 
 
 




Figure 189. 1H NMR spectrum of 20-Cl at 400 MHz in DMSO-d6 and CD3OD at 298K 
 
 
Figure 190. 13C NMR spectrum of 20-Cl at 101 MHz in DMSO-d6 and CD3OD at 298K 
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Figure 191. 1H NMR spectrum of 20-TFA at 600 MHz in DMSO-d6 at 298K 
 
 




Figure 193. 19F NMR spectrum of 20-TFA at 376 MHz in DMSO-d6 298K 
 
 




Figure 195. 13C NMR spectrum of 20-OAc at 151 MHz in CD3OD at 298K 
 
 




Figure 197. 13C NMR spectrum of 20-OTf at 101 MHz in DMSO-d6 at 298K 
 
 
Figure 198. 19F NMR spectrum of 20-OTf at 376 MHz in DMSO-d6 at 298K 
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Figure 199. 1H NMR spectrum of 20-BF4 at 400 MHz in DMSO-d6 at 298K 
 
 




Figure 201. 19F NMR spectrum of 20 - BF4 at 376 MHz in DMSO-d6 at 298K 
 
 




Figure 203. 13C NMR spectrum of 50 at 101 MHz in CDCl3 at 298K 
 
 
Figure 204. 1H NMR spectrum of 51 at 600 MHz in CDCl3 at 298K 
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Figure 205. 13C NMR spectrum of 51 at 151 MHz in CDCl3 at 298K 
 
 




Figure 207. 13C NMR spectrum of 56 at 101 MHz in CDCl3  at 298K 
 
 
Figure 208. 1H NMR spectrum of 57 at 400MHz in CDCl3 at 298K 
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Figure 209. 13C NMR spectrum of 57 at 101 MHz in CDCl3 at 298K 
 
 
Figure 210. 1H NMR spectrum of 58 at 400MHz in CDCl3 at 298K 
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Figure 211. 13C NMR spectrum of 58 at 101 MHz in CDCl3 at 298K 
 
 
Figure 212. 1H NMR spectrum of 59 at 400MHz in CDCl3 at 298K 
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Figure 213. 13C NMR spectrum of 59 at 101 MHz in CDCl3 at 298K 
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